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Genomic Stability Requires DNA Repair 
The human genome contains 12.6 billion deoxynucleotides. Separated into 23 
chromosome pairs, the largest chromosome in humans is a polymer nearly half a billion 
deoxynucleotides long. Maintaining the integrity of a such a large biomolecule poses a 
significant challenge to the cell, as the genome is constantly bombarded with reactive 
chemicals (1). Chemical reactions with endogenenous and exogenous sources lead to the 
modification of up to 100,000 nucleotides a day (2). These covalent modifications can 
interfere with fundamental processes of cell function such as transcription and replication 
(3).  
Many types of DNA damage are mutagenic, promoting permanent alterations to 
the genome (4). Mutations lead to diversity among our species, and genetic diversity can 
provide circumstantial advantages (5). Conversely, mutations are often detrimental to cell 
function and are intimately associated with disease (6). Remarkably, the human cell 
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At least 125 genes, making up six major pathways of DNA repair, contribute to 
maintaining an incredibly low rate of mutations (8) (Figure 1-1)1. Most pathways of DNA 
repair function by removing the damaged DNA. Repair synthesis replaces the damaged 
DNA, taking advantage of the duplex structure of DNA to restore the correct nucleotide 
sequence. (9). Specifically, the base excision repair (BER) pathway is  
1Not illustrated in Figure 1-1 is repair by direct reversal. This unique process reverses covalent 
modifications to DNA without requiring the commonly employed cycle of removal and replacement of 




Figure 1-1. DNA damage can manifest itself in many forms and requires several pathways for 
accurate repair. Double strand break (DSB) repair is carried out by either homologous recombination (HR) 
or non-homologous end joining (NHEJ). Nucleotide excision repair (NER) removes DNA helix distorting 
lesions such as bulky adducts and crosslinked nucleotides. Base lesions resulting from relatively small 
modifications that do not impose significant distortions in the DNA are repaired the base excision repair 
(BER) pathway. Mismatched nucleotides are one type of error restored by the mismatch repair (MMR) 
pathway. Additionally, MMR repairs unpaired nucleotide bulges and other secondary structured loops that 
can occur during replication or recombination events. 
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responsible for removal and replacement of individual damaged nucleotides, where 
dimerized, cross-linked, and bulky lesions are repaired by nucleotide excision repair 
(NER). Mismatch repair (MMR) can be coupled with DNA replication to provide repair 
of mismatched and unpaired nucleotides that result from polymerase errors during 
replication (11). Homologous recombination (HR) and non-homologous end joining 
(NHEJ) represent repair of double strand breaks. In short, each repair pathway specializes 
in repairing distinct classes of DNA damage. 
Insufficient DNA repair activity in individuals manifests as premature aging, 
increased occurrence of cancer, and shortened lifespan (12). These hallmarks of 
insufficient DNA repair activity can originate from inactivation of DNA repair genes by 
both hereditary and somatic mutations. Additionally, there is abundant evidence for 
epigenetic misregulation contributing to DNA repair dysfunction by altering expression 
of DNA repair genes (13-15). Dysfunctional DNA repair can lead to an accumulation of 
DNA damage, resulting in an increased rate of mutations. Acceleration of the mutation 
rate, termed genomic instability, can trigger global cellular responses to enter senescence 
or apoptosis (16). Importantly, it is the mutations that inhibit cellular responses to 
genome instability that are known to drive development of carcinogenesis (17). The 
function of DNA repair pathways and the impact of DNA repair dysfunction will be 
discussed further.  
Repair of Double Strand DNA Breaks 
Double strand breaks are particularly cytotoxic due to fragmentation of 
chromosomal DNA leading to rearrangement or loss of large amounts of genomic 
material. Although rare, double strand breaks pose a monumental threat to genome 
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stability, and appropriately, attract significant attention from the cell. The eukaryotic 
DNA damage response can halt cell cycle progression and provoke significant changes in 
gene expression to give extra time for repair of breaks. Ultimately, persisting breaks can 
lead to cell destruction by apoptosis (18). Ataxia telangiectasia (AT) is a hereditary 
genetic disease due to the dysfunction of the ATM dependent DNA damage response, 
and is characteristic of severe genomic instability and ~100-fold increase in cancer 
susceptibility (19).  
Two distinct pathways exist for repair of double strand breaks, homologous 
recombination (HR) and non-homologous end-joining (NHEJ). Both pathways work to 
reunite the ends of the DNA at the break site, however, the relative contribution of these 
two pathways to break repair is influenced by several cellular processes including the 
status of the cell cycle (20). 
Repair of DNA Helix Distorting Damage 
High-energy radiation can induce major structural distortions in the chromosomal 
DNA through formation of intra- and interstrand crosslinks (21). Xeroderma 
pigmentosum (XP) is a hereditary disease characterized by enhanced photosensitivity 
leading to a >1000-fold increased chance in developing UV-induced skin cancer. XP is a 
result of defects in the nucleotide excision repair (NER) pathway (22). NER is adept at 
repairing duplex distorting bulky lesions and covalently dimerized nucleotides that are 
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Non-distorting DNA Damage 
Smaller, less structurally distorting lesions occur at a high frequency in the 
genome. It has been estimated that 100,000 lesions are created each day in a human cell 
as a result of endogenous and exogenous chemicals reacting with DNA (1)2. Reactive 
oxygen species formed during aerobic cellular respiration are thought to be the most 
significant contributor to the formation of damaged nucleotides. (24). Specifically, 
hydrogen peroxide, hydroxyl radials, and singlet oxygen can oxidize nucleic acids at 
several different positions (25). Reports have documented that up to 10,000 8-oxoguanine 
(8oxoG) lesions are produced per day due to oxidation at the C8 position of guanine (26). 
Additionally, the loss of exocylic amines via deamination can occur spontaneously and is 
accelerated in the presence of nitrogen oxides (27, 28). Several studies report an 
estimated 500 pyrimidines are deaminated per day (1, 29). Specifically, deamination of 
cytosine creates uracil. 5-methylcytosine, a modification used as an epigenetic marker, 
induces a higher rate of deamination than cytosine, resulting in formation of thymine.  
Alkylating agents transfer one or more carbon atoms to DNA. Common alkylating 
agents are N-nitroso compounds acquired exogeneously from airborne pollutants like 
tobacco smoke (30). Additionally, S-adenosylmethionine (SAM) is a vital molecule in 
many biological processes, but can spontaneously transfer the methyl group to DNA (31).  
2Unperturbed by chemical agents, DNA degrades at a significant rate, producing an estimated 10,000 
spontaneous depurinations in the genome per day (32, 33) The resulting abasic sites are processed by the 
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Both purine and pyrimidine nucleobases are susceptible to alkylation at several positions, 
including ring nitrogen atoms and exocyclic oxygen atoms (34). Most frequently,  
alkylation reactions occur at the N7 position of guanine and account for 60-80% of 
alkylative modifications. The N3 position of adenine is also susceptible to alkylation, 
contributing 20-30% of total alkylation modifications to DNA (35), with other ring 
nitrogen atoms accumulating modifications at much lower rates (34). Ethylation, the 
addition of two carbon atoms, can occur in significant amounts due to exposure to vinyl 
chloride. Vinyl chloride is metabolized to 2-chloroacetaldehyde in the liver and can 
produce several purine adducts, N1,6-ethenoadenine, as well as N1,2-ethenoguanine and 
N2,3-ethenoguanine (36). 
DNA Glycosylase Initiated Repair of Non-distorting Lesions 
In general, lesions in the genome must be repaired prior to a replication event to 
prevent mutations. DNA glycosylases catalyze the removal of damaged nucleotides from 
the genome. As many damaged nucleotides are not strikingly altered in structure, 
distinguishing a damaged nucleotide from the enormous excess of undamaged 
nucleotides poses a unique challenge to glycosylase catalysis. Further, the spectrum of 
damaged nucleotides varies significantly in shape, size, and charge, providing too much 
substrate diversity for one active site. Therefore, the human cell employs 11 different 
glycosylases (Table 1-1). Each glycosylase is responsible for recognizing a single lesion 
or small subset of damaged nucleotides.  
Four different glycosylase structural superfamilies are present in the human 
glycosylase proteome. There is evidence that the different structural families evolved 
independently, yet several core features of catalysis are ubiquitously found among all 
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glycosylases (37). To gain access to a nucleotide in duplex DNA, a glycosylase rotates 
the nucleotide 180o degrees, flipping the nucleotide into the active site. This mechanism, 
termed base-flipping, is a common mechanism for accessing a nucleotide buried in the 
duplex structure of DNA (38). In concert with rotation of the nucleotide out of the DNA 
duplex, a bend is locally induced in the DNA. DNA bending has been proposed to 
facilitates nucleotide flipping (39). The final feature of base-flipping is the insertion of an 
intercalating loop into the gap vacated by the flipped nucleotide.  
Once a damaged nucleotide is bound in the active site, the N-glycosidic bond can 
be hydrolyzed and the nucleobase liberated, leaving an abasic site. Two general 
mechanisms for N-glycosidic bond hydrolysis are employed (Figure 1-2). 
Monofunctional glycosylases activate a water molecule to promote nucleophilic attack on 
the C1 position of the deoxyribose sugar, catalyzing N-glycosidic bond cleavage by a 
nuclephilic substitution mechanism (39). An alternative mechanism for N-glycosidic 
	  
	  
Table 1-1. Human glycosylase proteome consists of 11 different glycosylases 
from four distinct structural families.  
Structural Family Glycosylase Mechanism 
Helix-hairpin-Helix Nth1 Bifunctional 
 Ogg1 Bifunctional 
 MutY Bifunctional 
 MBD4 Monofunctional 
Uracil DNA Glycosylase UDG Monofunctional 
 SMUG1 Monofunctional 
 TDG Monofunctional 
 NEIL1 Bifunctional 
FapyG DNA Glycosylase NEIL2 Bifunctional 
 NEIL3 Bifunctional 
Alkyladenine DNA 
Glycosylase AAG Monofunctional 
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bond cleavage uses nucleophilic attack from an active site amine on the C1 position of 
the deoxyribose sugar, forming a covalent Schiff base intermediate (39). As a result of 
the covalent intermediate, an elimination of the 3’-phosphate at the β position can form a 
DNA break at the lesion site3. Since both lesion excision and breakage of the DNA 
backbone are required steps for repair of a damaged nucleotide, bifunctional glycosylase 
activity can contribute the first two steps required for repair of a damaged nucleotide 4. 
Although the mechanism for excision of a damaged nucleotide is largely 
conserved within each glycosylase family, the recognition of a specific lesion or subset of 
lesions requires unique contributions by each glycosylase. Uracil DNA glycosylase 
(UNG) removes uracil from DNA with astonishing efficiency (40). Fortuitously, uracil is 
the smallest nucleobase and specificity for uracil can be achieved by a sterically 
constrained active site that occludes all other nucleobases (41). In contrast, 
akyladenine DNA glycosylase5 removes a diverse array of damaged purines (35). Broad 
recognition of a range of different lesions is achieved by strategic positioning of active 
site residues to block exocyclic amines of guanine and adenine. Secondly, as pyrimidines 
cannot be excluded by an active site large enough to accommodate purine nucleobases, 
the use of acid/base catalysis to simultaneously protonate the nucleobase in the active site 
and activate a water molecule for nucleophilic attack is incompatible with 
3Fapyguanine (Fpg) family of DNA glycosylases utilize a bifunctional mechanism that can perform both a 
β and δ elimination reaction on a abasic site. 4Bifunctional glycosylase activity is not obligatory. The 
covalent Schiff base intermediate can be hydrolyzed to produce only an abasic site, unsuccessfully 
performing the β−elimination strand cleavage reaction. 5AAG is also known as methylpurine DNA 
glycosylase (MPG) and 3MeA DNA glycosylase. 
 
 








Figure 1-2. Mechanisms of N-glycosidic bond cleavage by a DNA glycosylase. (A) The mechanism 
for monofunctional glycosylase catalysis utilizes an activated water molecule as the nucleophile in a 
nucleophilic substitution reaction. The nucleophilic substitution reaction could occur by an associative 
or a dissociative substitution mechanism. The product of monofunctional glycosylase catalysis is an 
abasic site, in addition to the liberated nucleobase. (B) Bifunctional glycosylase catalysis utilizes a 
nucleophilic residue, forming a covalent intermediate upon N-glycosidic bond cleavage. The Schiff 
base intermediate can be hydrolyzed to dissolve the covalent intermediate, leaving an abasic site 
product. As illustrated, the Schiff base intermediate can proceed to break the DNA backbone through a 
β-elimination mechanism. Illustrations adapted from (39, 42). 
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cleavage of a pyrimidine nucleobase (42). As a consequence of broad substrate 
specificity, AAG incurs a reduced catalytic efficiency compared to UNG and catalyzes 
the removal of undamaged nucleotides at a slow rate (42, 43). 
Glycosylase catalysis removes a damaged nucleobase from the genome, 
producing an abasic product. Importantly, an abasic site is still a pro-mutagenic lesion, 
lacking any information to support DNA templating. Removal of abasic sites requires the 
activity of the BER pathway (Figure 1-3). Primary processing of abasic sites is performed 
by apurinic/apyrimidinic (AP)-endonuclease I (APE1). APE1 hydrolyzes the DNA 
backbone 5’ to the abasic site (44). At this point in the repair pathway, the nicked 
intermediate displays a 3’-OH that is compatible with polymerase extension. Short-patch 
BER pathway is performed by polymerase β. Polymerase β is non-processive and fills the 
gap with a new nucleotide. Polymerase β possesses a 5’-deoxyribose phosphate (dRP)-
lyase domain that subsequently removes the 5’-dRP moiety, leaving a ligatable nick (45) 6. 
Ligase is utilized by the BER pathway to complete repair (46). 
6Alternatively, long-patch DNA repair proceeds via the activity of a processive polymerase. Polymerase δ 
or ε can extend the nicked intermediate and incorporate several nucleotides, displacing several nucleotides 
and creating a flap. Flap endonuclease I (FEN1) removes the flap to allow a final ligation step (47). AP-
lyase activity provided by a bifunctional glycosylase can process an abasic site in a different manner than 
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Figure 1-3. The base excision repair pathway is initiated by a glycosylase. Repair is initiated by excision 
of the lesion (black filled circle) by a glycosylase. The identity of the glycosylase determines the 
downstream processing. All pathways require nicking of the DNA backbone by bifunctional a glycosylase 
or endonuclease activity from APE1. A common requirement for all pathways is the incorporation of a new, 
undamaged nucleotide by polymerase β. Ligation by Ligase I is the ubiquitous final step of BER.  
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Dysfunction of the BER pathway 
As described above, the BER pathway is highly divergent and can utilize several 
different enzymes to achieve the desired repair outcome. This provides redundant 
activities at each step in the pathway. Nevertheless, dysfunction of this repair pathway 
can lead to an overall increase in the mutation rate as the burden of damaged nucleotides 
are not removed from the genome. A DNA glycosylase initiates the pathway, providing 
lesion specificity. Knockout mice have been developed for several human glycosylase 
homologs, the majority maintaining healthy, fertile adults with weak or no phenotype. In 
fact, these studies lead to the discovery of several novel glycosylases due to redundant 
activities (48).  
Gene-targeted knockout of UNG in mice was expected to display the 50-fold 
increase in C-G to T-A transition mutations that was observed in the heterologous S. 
cerevisae experiment (49). Surprisingly, no observable phenotypic affects were observed, 
as the loss of UNG contributed only a 1.5-fold increase in the expected C-G to T-A 
transition mutations. Back-up repair of uracil lesions was attributed to the glycosylase 
named single-strand selective monofunctional uracil glycosylase (SMUG1) (50, 51). This 
was the first observation of redundant, overlapping activity in the glycosylase proteome 
and has been characterized for several human glycosylases activities. A similar result was 
reported when the human homolog of endonuclease III (Nth1) knockout was generated in 
mice. No abnormalities were observed in the mice over a two-year period. This 
seemingly non-informative result was instrumental in locating redundant repair of several 
pyrimidine lesions by the Neil family of glycosylases (52). Mice deficient in AAG (mpg) 
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were confirmed to lack glycosylase excision of several lesions that are known substrates 
for AAG, namely N1,6-ethenoadenine and hypoxanthine. Nevertheless, mice were healthy 
and viable. Only a modest increase in the accumulation of these lesions were observed, 
but other pathways may exist that don’t employ glycosylases including NER and direct 
repair (53). These mild phenotypes are in sharp contrast to the affects obtained by loss of 
downstream BER enzymes. Transgenic mice harboring APE1, polymerase β, or ligase I 
gene knockouts are embryonic lethal (54-56). Redundant BER activities exist for these 
enzymes, but appear to not be able to cope with the burden of repair intermediates7. 
Failure to remove lesions from the genome can lead to mutations. Nucleotides 
with small chemical modifications do not significantly distort duplex structure, but can 
alter the interactions used for templating reactions like replication and transcription (57). 
For example, an 8oxoG lesion can maintain the Watson-Crick interactions of the 
canonical G-C basepair, but can also support 8oxoG-A basepairing via a Hoogsteen mode 
(58). When DNA polymerase encounters 8oxoG, adenine may be incorporated, leading to 
a permanent mutation upon the subsequent round of replication. Mutation of a G-C to a 
T-A basepair at the location is termed a transversion mutation (59). Transversion 
mutations are promoted by several lesions, including uracil. Uracil formed from 
deamination of cytosine results in a U-G basepair. Replication of a U-G can lead to the  
7APE1, polymerase β, and ligase I may contribute essential processes during early embroyonic 
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misincorporation of an adenine and a C-G to T-A transversion (60). Lesions can also 
block replication and lead to stalling of the replication fork (61). 3-methyladenine does 
not impair basepairing with thymine. However, the methyl modification blocks DNA 
polymerization by causing a steric clash on the minor groove of the Watson-Crick 
basepairing face (62, 63).  
A stalled replication fork can be rescued by translesion DNA synthesis (TLS). A 
class of specialized translesion DNA polymerases exist that may be temporarily 
substituted for the replicative polymerase at the stalled fork in order effectively bypass an 
non-canonical or damaged nucleotide (64). Structural and biochemical data suggest that 
translesion polymerases facilitate lesion bypass by relaxing replication fidelity (65). Low-
fidelity replication by translesion bypass polymerases can result in mutations formed by 
misincorporation of an incorrect nucleotide (66). In addition to instigating miscoding 
mutations, several translesion bypass polymerases have been documented to increase the 
rate of insertion and deletion (67) mutations by >1000-fold in comparison to high fidelity 
replicative polymerases (68).  
Frameshift Mutagenesis  
Indel mutations are defined by the gain or loss of basepairs from the genome. 
Indels occurring within the reading frame of a gene are particularly deleterious to protein 
function due to the requirement that codons are transcribed in a group of three 
nucleotides, beginning from a defined start position. Therefore, indels of length 3n±1 
shift the frame codon sequence out of the intended frame of reference. A frameshift 
mutation alters the transcription of the gene product and commonly destroys protein 
function. Additionally, an out of frame gene may reveal an unintended stop codon and 
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lead to truncation of the gene product. In case of an indel mutation of 3n±0, the frame of 
reference is maintained but a change in the number of codons occurs. The insertion or 
deletion of additional codons can affect the protein structure of the gene product and is 
implicated in several diseases, including Huntington’s disease and oculopharyngeal 
muscular dystrophy (69). 
Several mechanisms for indel formation have been suggested, the first described 
over 40 years ago by Streisinger (70). The foundational concept for indel formation 
involves misalignment of the primer and template strands within the polymerase active 
site and generation of unpaired nucleotide(s). Misalignment can be generated by dNTP 
misincorporation (71). Insertion of an incorrect nucleotide impairs the ability to basepair 
directly with the opposing template, and subsequently, the incorrect nucleotide may shift 
to interact with an adjacent nucleotide8. This repositioning of the primer in the 
polymerase active site is termed polymerase slipping, and extension of the repositioned 
primer leaves one or more bulged, unpaired base(s). In the absence of repair, another 
round of replication will convert the bulged intermediate into a frameshift mutation and 
produce a trademark of one daughter cell with a frameshift mutation and one wildtype.  
8Misalignment of the primer and template strands could occur spontaneously, leading to the presentation of 
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As introduced by Streisinger, the classic model for polymerase slipping is 
promoted in regions of repetitive sequence (Figure 1-4). Consecutively repeating 
nucleotides, termed homopolymeric tracts, are more adept at fostering a misaligned 
intermediate due to a localized enrichment of supporting template basepairing partners. 
Longer homopolymeric tracts allow the misaligned intermediate to propagate away from 
the extending primer and better escape detection by polymerase proofreading 
mechanisms. The high propensity of slipping events in homopolymeric tracts can be 
offset by correcting bulged intermediates.  
Repair of Frameshift Mutation Intermediates 
A common feature of replicative DNA polymerases is the incorporation of a 
proofreading domain (72). The proofreading domain performs 3’ to 5’ exonucleolytic 
degradation of newly synthesized DNA if an error is detected. Deletion of the 
exonuclease domain from DNA polymerase highlight the role of polymerase 
proofreading in extension of misaligned primer-template strands. Studies conducted in S. 
cerevisiae measured the rate of frameshift mutations as a function of hompolymer tract 
length (73). Results of this study showed that polymerase proofreading activity is most 
efficient in homopolymeric tracts of eight nucleotides or less, consistent with the ability 
of longer tracts to sequester a bulged intermediate further away from the DNA 
polymerase (74).  
If a bulged intermediate escapes repair by DNA polymerase proofreading, then 
mismatch DNA repair pathway (MMR) serves as a backup to detect and repair 
immediately after replication. MMR provides recognition of a broad range of replication 
errors, from mismatched bases to small and large bulges produced by polymerase 




Figure 1-4. Streisinger model for polymerase slipping involves a misalignment of the primer and 
template strand. Extension of the misaligned intermediate forms a bulged, unpaired nucleotide 
intermediate. A following round of replication will produce a frameshift mutation. A deletion (-1 
frameshift) occurs due a bulge present in the template strand. Similarly, an insertion (+1 frameshift) 
occurs due to formation of a bulge on the newly synthesized strand. 
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slipping errors. In humans, two recognition complexes are utilized. MSH2α complex is a 
heterodimer constructed of MSH2 and MSH6 and confers high affinity for mismatches 
and small (1-2 nucleotide) bulges (75). Recognition of larger bulges is accomplished by 
MSH2β, a heterodimer between MSH2 and MLH3 (76). One of these two MSH2 
recognition complexes initiate MMR repair by binding to the DNA at the site of the error. 
After MSH2 binding, the MMR proceeds by selectively nicking the DNA strand with the 
error and then degrading approximately one kilobase of DNA. Re-synthesis of the 
degraded region by a replicative polymerase completes the repair pathway (77). A critical 
feature of MMR is the ability to detect the newly synthesized strand. This feature aids in 
determining which nucleotide in a mismatch or bulge is incorrect. 
Dysfunction of the MMR pathway results in an elevated rate of replication errors, 
predominantly base substitutions and indels. Remarkably, inactivation of MMR in S. 
cerevisiae increased the rate of frameshift mutations by 10,000-fold in a repetitive, 
polyadenine tract. As stated above, indels occur with significantly higher frequency in 
repetitive sequences. Hereditary defects in MMR function predispose individuals for 
colon cancer. Commonly referred to as hereditary non-polypopsis colon cancer (HNPCC), 
individuals with this condition have a significant risk of developing early onset colon 
cancer (78, 79). HNPCC is clinically diagnosed by instability in the length of repetitive 





	   19	  
Intriguingly, under conditions of functional MMR, overexpression of BER 
enzymes has been documented to result in microsatellite instability9. Upregulation of 
AAG positively correlated with microsatellite instability (81). Further, heterologous 
overexpression of AAG in S. cerevisiae leads to an increase in frameshift mutations at a 
repetitive sequence with a 30-fold bias toward -1 frameshift mutations. As the induction 
of microsatellite instability can be attributed to lack of MMR repair activity on bulged 
intermediates, the mechanism for a glycosylase mediated frameshift mutation is likely to 
involve competition between AAG and the MMR pathway for repair of a bulged 
intermediate. 
Human BER creates a bias for -1 frameshift mutations 
My doctoral work examined the mechanism by which BER contributes to 
frameshift mutagenesis. We determined the ability of glycosylases to catalyze the 
excision of a bulged nucleotide in chapter 2. Several different damaged and undamaged 
nucleotides were presented in a single nucleotide bulge structure in HeLa whole cell 
extract. Undamaged, bulged nucleotides remained stable against excision. Contrarily, 
several types of bulged lesions were rapidly excised in HeLa extract. Targeted inhibition 
confirmed the identity of two glycosylases that were responsible for the bulge excision 
activity that was observed in HeLa extract, UDG and AAG. 
9Overexpression of polymerase β was shown to increase the rate of -1 frameshift mutations due to an 
increase in the propensity for formation of slipped intermediates (82). Polymerase β is a non-processive 
polymerase. Excess polymerase β was suggested to act in a processive manner, but with increased 
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A bulged lesion may arise in vivo due to polymerase slippage on a damaged 
template (70). Alternatively, undamaged bulged bases may be more susceptible to DNA 
damage. We showed that an undamaged, bulged adenine is at least 20-fold more 
susceptible to incurring damage than adenine basepaired to thymine. The lack of a base 
directly opposing the bulged nucleotide increases the dynamics of the bulged nucleotide . 
The increased dynamics are expected to raise the exposure of a bulged nucleotide to 
deamination and alkylation damage. 
Under physiological conditions, several human cancer cell extracts had the ability 
to process a bulged lesion to a single nucleotide deletion. Reconstitution of the short 
patch BER pathway with recombinant human proteins demonstrated that the processing 
of each enzyme closely follows the canonical pathway for repair of a lesion with an 
opposing base. Activity of BER is expected to give a bias toward deletion mutation by 
repairing +1 insertions and making -1 deletions permanent (Figure 1-5). 
In order to determine the extent of AAG discrimination against a bulged lesion, 
the efficiency of AAG excision of a bulged lesion was measured in chapter 3. Compared 
to a basepaired I-T mismatch, an inosine bulge is excised with a 3-fold greater catalytic 
efficiency. By comparing inosine excision in several structural contexts, the efficiency of 
inosine excision was found to correlate inversely with the stability of the inosine 
interaction with the opposing base. High efficiency excision of a bulged lesion is likely 
due to a significantly reduced barrier to base-flipping. Therefore, AAG doesn’t 
discriminate against excision of a bulged lesion, suggesting that AAG will be able to 
compete for bulged species in vivo. 
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We performed similar kinetic analysis to quantify the ability of Nth1 to recognize 
a bulged lesion in chapter 4. In contrast to the 3-fold increase in affinity for a bulged 
lesion that was observed by AAG, the relative affinity of Nth1 for a bulged lesion was 
20-fold reduced compared to a mismatched lesion. Although, Nth1 discriminates against 
excision of a bulged lesion, the maximal turnover rate of Nth1 for a 5,6-dihydrouracil  
(DHU) lesion is the same regardless of structural context. Reconstitution of the BER 
pathway showed that Nth1 can initiate deletion of a DHU-bulge. Additionally, HeLa 
nuclear extract possessed the ability to process a DHU-bulge to a single nucleotide 
deletion on a similar timescale as the repair of a canonical DHU-G. This demonstrates 
that in spite of a reduction in affinity, there is sufficient glycosylase activity to excise a 
DHU-bulge.  
Bulge excision appears to be a common characteristic of glycosylase catalysis 
because glycosylases from all four known structural families share this activity (84-86). It 
is likely that glycoyslases have some flexibility. This flexibility allows the nucleotide to 
be flipped into the glycosylase active site in spite of structural distortions induced in the 
DNA by a bulged nucleotide. Our results raise the possibility that other base-flipping 











Figure 1-5. BER creates a bias for -1 frameshift mutations. Polymerase slipping can create a 
bulged, unpaired nucleotide intermediate. A -1 slip is illustrated as skipping over the replication of 
a nucleotide in reference to the template strand (black), where a +1 slip involves the insertion of an 
extra nucleotide in the newly synthesized strand (red). A bulged nucleotide is expected to have 
increased susceptiblilty to alkylation and deamination reactions. Processing of the bulged lesion by 
the BER pathway would ultimately lead to deletion of the bugled lesion. The BER deletion 
pathway would be expected to convert -1 slipping events into a -1 frameshift mutation, but repair 
+1 slipping events to create a bias for -1 frameshift mutations. Replication coupled MMR can 
provide accurate repair of either a +1 or -1 slipping event.  
	  
5’	  





1. Lindahl, T., Instability and decay of the primary structure of DNA. Nature, 1993. 
362(6422): p. 709-715. 
2. Ciccia, A. and S.J. Elledge, The DNA damage response: making it safe to play 
with knives. Mol Cell. 40(2): p. 179-204. 
3. Jacobs, A.L. and P. Schar, DNA glycosylases: in DNA repair and beyond. 
Chromosoma. 121(1): p. 1-20. 
4. Hsu, G.W., M. Ober, T. Carell, and L.S. Beese, Error-prone replication of 
oxidatively damaged DNA by a high-fidelity DNA polymerase. Nature, 2004. 
431(7005): p. 217-221. 
5. Caporale, L.H., Chance favors the prepared genome. Ann N Y Acad Sci, 1999. 
870: p. 1-21. 
6. Jackson, A.L. and L.A. Loeb, On the origin of multiple mutations in human 
cancers. Semin Cancer Biol, 1998. 8(6): p. 421-429. 
7. Loeb, L.A., Mutator phenotype may be required for multistage carcinogenesis. 
Cancer Res, 1991. 51(12): p. 3075-3079. 
8. Friedberg, E.C., A. Aguilera, M. Gellert, P.C. Hanawalt, J.B. Hays, A.R. 
Lehmann, T. Lindahl, N. Lowndes, A. Sarasin, and R.D. Wood, DNA repair: 
from molecular mechanism to human disease. DNA Repair (Amst), 2006. 5(8): p. 
986-996. 
9. Nordstrand, L.M., J. Ringvoll, E. Larsen, and A. Klungland, Genome instability 
and DNA damage accumulation in gene-targeted mice. Neuroscience, 2007. 
145(4): p. 1309-1317. 
10. Sedgwick, B., P. Robins, and T. Lindahl, Direct removal of alkylation damage 
from DNA by AlkB and related DNA dioxygenases. Methods Enzymol, 2006. 408: 
p. 108-120. 
11. Lindahl, T. and R.D. Wood, Quality control by DNA repair. Science, 1999. 
286(5446): p. 1897-1905. 
12. Knoch, J., Y. Kamenisch, C. Kubisch, and M. Berneburg, Rare hereditary 
diseases with defects in DNA-repair. Eur J Dermatol. 
13. Imai, K. and H. Yamamoto, Carcinogenesis and microsatellite instability: the 
interrelationship between genetics and epigenetics. Carcinogenesis, 2008. 29(4): 
p. 673-680. 
14. Banno, K., I. Kisu, M. Yanokura, K. Tsuji, K. Masuda, A. Ueki, Y. Kobayashi, W. 
Yamagami, H. Nomura, E. Tominaga, N. Susumu, and D. Aoki, Epimutation and 
cancer: a new carcinogenic mechanism of Lynch syndrome (Review). Int J Oncol. 
15. Nowsheen, S., K. Aziz, P.T. Tran, V.G. Gorgoulis, E.S. Yang, and A.G. 
Georgakilas, Epigenetic inactivation of DNA repair in breast cancer. Cancer Lett. 
16. Lowe, S.W., E. Cepero, and G. Evan, Intrinsic tumour suppression. Nature, 2004. 
432(7015): p. 307-315. 
	   24	  
17. Greenman, C., P. Stephens, R. Smith, G.L. Dalgliesh, C. Hunter, G. Bignell, H. 
Davies, J. Teague, A. Butler, C. Stevens, S. Edkins, S. O'Meara, I. Vastrik, E.E. 
Schmidt, T. Avis, S. Barthorpe, G. Bhamra, G. Buck, B. Choudhury, J. Clements, 
J. Cole, E. Dicks, S. Forbes, K. Gray, K. Halliday, R. Harrison, K. Hills, J. Hinton, 
A. Jenkinson, D. Jones, A. Menzies, T. Mironenko, J. Perry, K. Raine, D. 
Richardson, R. Shepherd, A. Small, C. Tofts, J. Varian, T. Webb, S. West, S. 
Widaa, A. Yates, D.P. Cahill, D.N. Louis, P. Goldstraw, A.G. Nicholson, F. 
Brasseur, L. Looijenga, B.L. Weber, Y.E. Chiew, A. DeFazio, M.F. Greaves, A.R. 
Green, P. Campbell, E. Birney, D.F. Easton, G. Chenevix-Trench, M.H. Tan, S.K. 
Khoo, B.T. Teh, S.T. Yuen, S.Y. Leung, R. Wooster, P.A. Futreal, and M.R. 
Stratton, Patterns of somatic mutation in human cancer genomes. Nature, 2007. 
446(7132): p. 153-158. 
18. Roos, W.P. and B. Kaina, DNA damage-induced apoptosis: From specific DNA 
lesions to the DNA damage response and apoptosis. Cancer Lett. 
19. Zakian, V.A., ATM-related genes: what do they tell us about functions of the 
human gene? Cell, 1995. 82(5): p. 685-687. 
20. Jackson, S.P., Sensing and repairing DNA double-strand breaks. Carcinogenesis, 
2002. 23(5): p. 687-696. 
21. Masuda, Y. and K. Kamiya, Molecular nature of radiation injury and DNA repair 
disorders associated with radiosensitivity. Int J Hematol. 95(3): p. 239-245. 
22. Diderich, K., M. Alanazi, and J.H. Hoeijmakers, Premature aging and cancer in 
nucleotide excision repair-disorders. DNA Repair (Amst). 10(7): p. 772-780. 
23. Novarina, D., F. Amara, F. Lazzaro, P. Plevani, and M. Muzi-Falconi, Mind the 
gap: keeping UV lesions in check. DNA Repair (Amst). 10(7): p. 751-759. 
24. Klungland, A., I. Rosewell, S. Hollenbach, E. Larsen, G. Daly, B. Epe, E. Seeberg, 
T. Lindahl, and D.E. Barnes, Accumulation of premutagenic DNA lesions in mice 
defective in removal of oxidative base damage. Proc Natl Acad Sci U S A, 1999. 
96(23): p. 13300-13305. 
25. Cooke, M.S., M.D. Evans, M. Dizdaroglu, and J. Lunec, Oxidative DNA damage: 
mechanisms, mutation, and disease. FASEB J, 2003. 17(10): p. 1195-1214. 
26. Fraga, C.G., M.K. Shigenaga, J.W. Park, P. Degan, and B.N. Ames, Oxidative 
damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA 
and urine. Proc Natl Acad Sci U S A, 1990. 87(12): p. 4533-4537. 
27. Akbari, M. and H.E. Krokan, Cytotoxicity and mutagenicity of endogenous DNA 
base lesions as potential cause of human aging. Mech Ageing Dev, 2008. 129(7-
8): p. 353-365. 
28. Karran, P. and T. Lindahl, Hypoxanthine in deoxyribonucleic acid: generation by 
heat-induced hydrolysis of adenine residues and release in free form by a 
deoxyribonucleic acid glycosylase from calf thymus. Biochemistry, 1980. 19(26): 
p. 6005-6011. 
29. Frederico, L.A., T.A. Kunkel, and B.R. Shaw, A sensitive genetic assay for the 
detection of cytosine deamination: determination of rate constants and the 
activation energy. Biochemistry, 1990. 29(10): p. 2532-2537. 
30. Mishina, Y., E.M. Duguid, and C. He, Direct reversal of DNA alkylation damage. 
Chem Rev, 2006. 106(2): p. 215-232. 
	   25	  
31. Rydberg, B. and T. Lindahl, Nonenzymatic methylation of DNA by the 
intracellular methyl group donor S-adenosyl-L-methionine is a potentially 
mutagenic reaction. EMBO J, 1982. 1(2): p. 211-216. 
32. Overballe-Petersen, S., L. Orlando, and E. Willerslev, Next-generation 
sequencing offers new insights into DNA degradation. Trends Biotechnol. 30(7): 
p. 364-368. 
33. Lindahl, T. and B. Nyberg, Rate of depurination of native deoxyribonucleic acid. 
Biochemistry, 1972. 11(19): p. 3610-3618. 
34. Fu, D., J.A. Calvo, and L.D. Samson, Balancing repair and tolerance of DNA 
damage caused by alkylating agents. Nat Rev Cancer. 12(2): p. 104-120. 
35. Drablos, F., E. Feyzi, P.A. Aas, C.B. Vaagbo, B. Kavli, M.S. Bratlie, J. Pena-Diaz, 
M. Otterlei, G. Slupphaug, and H.E. Krokan, Alkylation damage in DNA and 
RNA--repair mechanisms and medical significance. DNA Repair (Amst), 2004. 
3(11): p. 1389-1407. 
36. Sambamurti, K., J. Callahan, X. Luo, C.P. Perkins, J.S. Jacobsen, and M.Z. 
Humayun, Mechanisms of mutagenesis by a bulky DNA lesion at the guanine N7 
position. Genetics, 1988. 120(4): p. 863-873. 
37. O'Brien, P.J. and D. Herschlag, Catalytic promiscuity and the evolution of new 
enzymatic activities. Chem Biol, 1999. 6(4): p. R91-R105. 
38. Dodson, M.L. and R.S. Lloyd, Mechanistic comparisons among base excision 
repair glycosylases. Free Radic Biol Med, 2002. 32(8): p. 678-682. 
39. Friedman, J.I. and J.T. Stivers, Detection of damaged DNA bases by DNA 
glycosylase enzymes. Biochemistry. 49(24): p. 4957-4967. 
40. Stivers, J.T. and A.C. Drohat, Uracil DNA glycosylase: insights from a master 
catalyst. Arch Biochem Biophys, 2001. 396(1): p. 1-9. 
41. Liu, P., A. Burdzy, and L.C. Sowers, Substrate recognition by a family of uracil-
DNA glycosylases: UNG, MUG, and TDG. Chem Res Toxicol, 2002. 15(8): p. 
1001-1009. 
42. O'Brien, P.J. and T. Ellenberger, Dissecting the broad substrate specificity of 
human 3-methyladenine-DNA glycosylase. J Biol Chem, 2004. 279(11): p. 9750-
9757. 
43. Berdal, K.G., R.F. Johansen, and E. Seeberg, Release of normal bases from intact 
DNA by a native DNA repair enzyme. EMBO J, 1998. 17(2): p. 363-367. 
44. Schild, L.J., K.W. Brookman, L.H. Thompson, and D.M. Wilson, 3rd, Effects of 
Ape1 overexpression on cellular resistance to DNA-damaging and anticancer 
agents. Somat Cell Mol Genet, 1999. 25(5-6): p. 253-262. 
45. Beard, W.A. and S.H. Wilson, Structural design of a eukaryotic DNA repair 
polymerase: DNA polymerase beta. Mutat Res, 2000. 460(3-4): p. 231-244. 
46. Tomkinson, A.E. and D.S. Levin, Mammalian DNA ligases. Bioessays, 1997. 
19(10): p. 893-901. 
47. Prasad, R., G.L. Dianov, V.A. Bohr, and S.H. Wilson, FEN1 stimulation of DNA 
polymerase beta mediates an excision step in mammalian long patch base 
excision repair. J Biol Chem, 2000. 275(6): p. 4460-4466. 
48. Wilson, D.M., 3rd and L.H. Thompson, Life without DNA repair. Proc Natl Acad 
Sci U S A, 1997. 94(24): p. 12754-12757. 
	   26	  
49. Impellizzeri, K.J., B. Anderson, and P.M. Burgers, The spectrum of spontaneous 
mutations in a Saccharomyces cerevisiae uracil-DNA-glycosylase mutant limits 
the function of this enzyme to cytosine deamination repair. J Bacteriol, 1991. 
173(21): p. 6807-6810. 
50. Nilsen, H., I. Rosewell, P. Robins, C.F. Skjelbred, S. Andersen, G. Slupphaug, G. 
Daly, H.E. Krokan, T. Lindahl, and D.E. Barnes, Uracil-DNA glycosylase (UNG)-
deficient mice reveal a primary role of the enzyme during DNA replication. Mol 
Cell, 2000. 5(6): p. 1059-1065. 
51. Kavli, B., O. Sundheim, M. Akbari, M. Otterlei, H. Nilsen, F. Skorpen, P.A. Aas, 
L. Hagen, H.E. Krokan, and G. Slupphaug, hUNG2 is the major repair enzyme for 
removal of uracil from U:A matches, U:G mismatches, and U in single-stranded 
DNA, with hSMUG1 as a broad specificity backup. J Biol Chem, 2002. 277(42): p. 
39926-39936. 
52. Takao, M., S. Kanno, K. Kobayashi, Q.M. Zhang, S. Yonei, G.T. van der Horst, 
and A. Yasui, A back-up glycosylase in Nth1 knock-out mice is a functional Nei 
(endonuclease VIII) homologue. J Biol Chem, 2002. 277(44): p. 42205-42213. 
53. Engelward, B.P., G. Weeda, M.D. Wyatt, J.L. Broekhof, J. de Wit, I. Donker, J.M. 
Allan, B. Gold, J.H. Hoeijmakers, and L.D. Samson, Base excision repair 
deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc Natl Acad Sci 
U S A, 1997. 94(24): p. 13087-13092. 
54. Ludwig, D.L., M.A. MacInnes, Y. Takiguchi, P.E. Purtymun, M. Henrie, M. 
Flannery, J. Meneses, R.A. Pedersen, and D.J. Chen, A murine AP-endonuclease 
gene-targeted deficiency with post-implantation embryonic progression and 
ionizing radiation sensitivity. Mutat Res, 1998. 409(1): p. 17-29. 
55. Sugo, N., Y. Aratani, Y. Nagashima, Y. Kubota, and H. Koyama, Neonatal 
lethality with abnormal neurogenesis in mice deficient in DNA polymerase beta. 
EMBO J, 2000. 19(6): p. 1397-1404. 
56. Bentley, D.J., C. Harrison, A.M. Ketchen, N.J. Redhead, K. Samuel, M. Waterfall, 
J.D. Ansell, and D.W. Melton, DNA ligase I null mouse cells show normal DNA 
repair activity but altered DNA replication and reduced genome stability. J Cell 
Sci, 2002. 115(Pt 7): p. 1551-1561. 
57. Shibutani, S., Quantitation of base substitutions and deletions induced by 
chemical mutagens during DNA synthesis in vitro. Chem Res Toxicol, 1993. 6(5): 
p. 625-629. 
58. Bruner, S.D., D.P. Norman, and G.L. Verdine, Structural basis for recognition 
and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature, 2000. 
403(6772): p. 859-866. 
59. Shibutani, S., M. Takeshita, and A.P. Grollman, Insertion of specific bases during 
DNA synthesis past the oxidation-damaged base 8-oxodG. Nature, 1991. 
349(6308): p. 431-434. 
60. Barnes, D.E. and T. Lindahl, Repair and genetic consequences of endogenous 
DNA base damage in mammalian cells. Annu Rev Genet, 2004. 38: p. 445-476. 
61. Mirkin, E.V. and S.M. Mirkin, Replication fork stalling at natural impediments. 
Microbiol Mol Biol Rev, 2007. 71(1): p. 13-35. 
62. Larson, K., J. Sahm, R. Shenkar, and B. Strauss, Methylation-induced blocks to in 
vitro DNA replication. Mutat Res, 1985. 150(1-2): p. 77-84. 
	   27	  
63. Plosky, B.S., E.G. Frank, D.A. Berry, G.P. Vennall, J.P. McDonald, and R. 
Woodgate, Eukaryotic Y-family polymerases bypass a 3-methyl-2'-
deoxyadenosine analog in vitro and methyl methanesulfonate-induced DNA 
damage in vivo. Nucleic Acids Res, 2008. 36(7): p. 2152-2162. 
64. Friedberg, E.C., A.R. Lehmann, and R.P. Fuchs, Trading places: how do DNA 
polymerases switch during translesion DNA synthesis? Mol Cell, 2005. 18(5): p. 
499-505. 
65. Zahn, K.E., S.S. Wallace, and S. Doublie, DNA polymerases provide a canon of 
strategies for translesion synthesis past oxidatively generated lesions. Curr Opin 
Struct Biol. 21(3): p. 358-369. 
66. Broyde, S., L. Wang, O. Rechkoblit, N.E. Geacintov, and D.J. Patel, Lesion 
processing: high-fidelity versus lesion-bypass DNA polymerases. Trends Biochem 
Sci, 2008. 33(5): p. 209-219. 
67. Orengo, C.A., A.D. Michie, S. Jones, D.T. Jones, M.B. Swindells, and J.M. 
Thornton, CATH--a hierarchic classification of protein domain structures. 
Structure, 1997. 5(8): p. 1093-1108. 
68. Matsuda, T., K. Bebenek, C. Masutani, I.B. Rogozin, F. Hanaoka, and T.A. 
Kunkel, Error rate and specificity of human and murine DNA polymerase eta. J 
Mol Biol, 2001. 312(2): p. 335-346. 
69. Davies, J.E. and D.C. Rubinsztein, Polyalanine and polyserine frameshift 
products in Huntington's disease. J Med Genet, 2006. 43(11): p. 893-896. 
70. Streisinger, G., Y. Okada, J. Emrich, J. Newton, A. Tsugita, E. Terzaghi, and M. 
Inouye, Frameshift mutations and the genetic code. This paper is dedicated to 
Professor Theodosius Dobzhansky on the occasion of his 66th birthday. Cold 
Spring Harb Symp Quant Biol, 1966. 31: p. 77-84. 
71. Kunkel, T.A., Frameshift mutagenesis by eucaryotic DNA polymerases in vitro. J 
Biol Chem, 1986. 261(29): p. 13581-13587. 
72. Garcia-Diaz, M., K. Bebenek, J.M. Krahn, L. Blanco, T.A. Kunkel, and L.C. 
Pedersen, A structural solution for the DNA polymerase lambda-dependent repair 
of DNA gaps with minimal homology. Mol Cell, 2004. 13(4): p. 561-572. 
73. Tran, H.T., J.D. Keen, M. Kricker, M.A. Resnick, and D.A. Gordenin, 
Hypermutability of homonucleotide runs in mismatch repair and DNA polymerase 
proofreading yeast mutants. Mol Cell Biol, 1997. 17(5): p. 2859-2865. 
74. Modrich, P., Mechanisms and biological effects of mismatch repair. Annu Rev 
Genet, 1991. 25: p. 229-253. 
75. Palombo, F., P. Gallinari, I. Iaccarino, T. Lettieri, M. Hughes, A. D'Arrigo, O. 
Truong, J.J. Hsuan, and J. Jiricny, GTBP, a 160-kilodalton protein essential for 
mismatch-binding activity in human cells. Science, 1995. 268(5219): p. 1912-
1914. 
76. Palombo, F., I. Iaccarino, E. Nakajima, M. Ikejima, T. Shimada, and J. Jiricny, 
hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion 
loops in DNA. Curr Biol, 1996. 6(9): p. 1181-1184. 
77. Jiricny, J., The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol, 2006. 
7(5): p. 335-346. 
78. Watson, P. and H.T. Lynch, Cancer risk in mismatch repair gene mutation 
carriers. Fam Cancer, 2001. 1(1): p. 57-60. 
	   28	  
79. Jenkins, M.A., L. Baglietto, J.G. Dowty, C.M. Van Vliet, L. Smith, L.J. Mead, 
F.A. Macrae, D.J. St John, J.R. Jass, G.G. Giles, J.L. Hopper, and M.C. Southey, 
Cancer risks for mismatch repair gene mutation carriers: a population-based 
early onset case-family study. Clin Gastroenterol Hepatol, 2006. 4(4): p. 489-498. 
80. Liu, B., R. Parsons, N. Papadopoulos, N.C. Nicolaides, H.T. Lynch, P. Watson, 
J.R. Jass, M. Dunlop, A. Wyllie, P. Peltomaki, A. de la Chapelle, S.R. Hamilton, 
B. Vogelstein, and K.W. Kinzler, Analysis of mismatch repair genes in hereditary 
non-polyposis colorectal cancer patients. Nat Med, 1996. 2(2): p. 169-174. 
81. Hofseth, L.J., M.A. Khan, M. Ambrose, O. Nikolayeva, M. Xu-Welliver, M. 
Kartalou, S.P. Hussain, R.B. Roth, X. Zhou, L.E. Mechanic, I. Zurer, V. Rotter, 
L.D. Samson, and C.C. Harris, The adaptive imbalance in base excision-repair 
enzymes generates microsatellite instability in chronic inflammation. J Clin Invest, 
2003. 112(12): p. 1887-1894. 
82. Chan, K., S. Houlbrook, Q.M. Zhang, M. Harrison, I.D. Hickson, and G.L. 
Dianov, Overexpression of DNA polymerase beta results in an increased rate of 
frameshift mutations during base excision repair. Mutagenesis, 2007. 22(3): p. 
183-188. 
83. Kunkel, T.A., The mutational specificity of DNA polymerase-beta during in vitro 
DNA synthesis. Production of frameshift, base substitution, and deletion 
mutations. J Biol Chem, 1985. 260(9): p. 5787-5796. 
84. Zhao, X., N. Krishnamurthy, C.J. Burrows, and S.S. David, Mutation versus 
repair: NEIL1 removal of hydantoin lesions in single-stranded, bulge, bubble, 
and duplex DNA contexts. Biochemistry. 49(8): p. 1658-1666. 
85. Lyons, D.M. and P.J. O'Brien, Efficient recognition of an unpaired lesion by a 
DNA repair glycosylase. J Am Chem Soc, 2009. 131(49): p. 17742-17743. 
86. Lyons, D.M. and P.J. O'Brien, Human base excision repair creates a bias toward -
1 frameshift mutations. J Biol Chem. 285(33): p. 25203-25212. 
 
 





HUMAN BASE EXCISION REPAIR CREATES A BIAS FOR -1 FRAMESHIFT 
MUTATIONS 
 
The loss or gain of one or more base pairs is one of the most common types of 
genetic instability (1). Single nucleotide deletions or insertions occur more frequently 
than larger deletions or insertions and they cause frameshift mutations if they occur 
within the open reading frame of a gene. Genomic instability is proposed to be a hallmark 
of carcinogenesis and the loss or alteration of DNA replication or repair pathways is an 
early step in the progression of cancer (2, 3). Normally the mismatch DNA repair (MMR) 
pathway suppresses frameshift mutations by performing replication-coupled DNA repair, 
but many cancer cells inactivate this pathway through mutations or changes in promoter 
methylation that reduce expression of one or more proteins in this pathway (4-6). 
However, not all cases of increased frameshift frequency can be attributed to defects in 
MMR (7, 8). Here we consider the possibility that other DNA repair pathways might also 
play a role in frameshift mutagenesis.  
1This research was originally published in Journal of Biological Chemistry. Derek M. Lyons and Patrick J. 
O’Brien. Human Base Excision Repair Creates a Bias for -1 Frameshift Mutations. Journal of Biological 
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Many of the factors that influence the frequency of frameshift mutations are know 
(9, 10) Streisinger and co-workers (11) proposed that slipping of primer/template pair 
within a polymerase active site could lead to a misaligned intermediate that would 
subsequently be extended to generate a bulged intermediate. Subsequent models for 
frameshift mutations (1, 6), including the effects of damaged templates and DNA 
intercalators (12, 13), have incorporated this essential feature (Figure 2-1). It is generally 
assumed that another round of DNA replication is required to make this frameshift event 
permanent, with one copy that retains the original sequence and another copy that is 
mutant. Although both -1 and +1 frameshifts occur, human cells show a strong bias (3-6 
–fold) toward -1 frameshift mutations (14-16). This bias had been attributed to the 
intrinsic propensity for some polymerases to make more frequent -1 than +1 errors. For 
example, yeast polymerase δ generates a greater number of -1 slips (17). Here we have 
considered the possibility that alternative DNA repair pathways recognize frameshift 




Figure 2-1. Polymerase slipping creates bulged intermediates that give rise to frameshift 
mutations. Arrows indicate DNA replication events. Slipping of polymerases generate a bulged 
nucleotide (N) that is less likely to be corrected by proofreading if it occurs in a 
homopolymeric sequence (A) (11). The probability of a polymerase slipping is increased by 
DNA intercalators (B) (12), or by a damaged template (C) (43,45). Slipping on a damaged 
nucleotide (X) generates a damaged bulge. MMR can correct these errors, whereas an 
additional round of replication makes the frameshift permanent. 
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The base excisions repair (BER) pathway is one DNA repair pathway that might 
compete against MMR, because the overexpression of BER enzymes result in increased 
frequency of point mutations and frameshift mutations, especially -1 frameshifts (18-20). 
The BER pathway repairs the majority of damaged bases that arise from spontaneous 
hydrolytic, oxidative, or alkylative reactions (for reviews, see Ref, 21-23). This pathway 
is initiated by glycosylases that locate sites of damage and excise the lesion base. A few 
of these enzymes also nick the DNA backbone via a lyase mechanism. But most release 
an apurinic/apyrimidinic (AP) product. The AP site is subsequently hydrolyzed by AP 
endonuclease 1 (APE1) to create a 3’-hydoxyl and a 5’-deoxyribose phosphate (dRP) 
group. Commonly the missing nucleotide is incorporated by DNA polymerase b, which 
also removes the 5’-dRP group via a lyase reaction. Finally, the single stand nick is 
ligated to complete the BER pathway. This pathway removes the damaged nucleotide and 
inserts a new nucleotide based upon base pairing with the opposing nucleotide however, 
if the BER pathway were initiated on a single nucleotide bulge, then it would be expected 
to delete the bulged nucleotide.  
In this study we tested the hypothesis that the human BER pathway can delete 
bulged nucleotides, by performing DNA repair assays in cell extracts and reconstituting 
the BER pathway with purified components. The results demonstrates that the BER 
pathway is active toward alkylated or deaminated nucleotide bulges, and confirm that the 
deletion of the damaged nucleotide closely follows the well characterized activities of the 
BER enzymes. Damaged single nucleotide bulges could arise from the slipping of a 
polymerase on a damaged template, or could result from spontaneous damage of an 
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undamaged bulge. These observations suggest the BER may compete against MMR and 
that this competition could contribute to the bias toward single nucleotide deletions. 
MATERIALS AND METHODS 
Recombinant Proteins 
  Human BER enzymes were expressed in Escherichia coli and purified by affinity 
and ion exchange chromatography. The affinity tags were removed and purity was judged 
to be >95% by SDS-PAGE analysis with Coomassie staining. The purification of the 
catalytic domain of AAG (∆80), lacking the first 79 amino acids (24), the catalytic 
domain of DNA ligase I (∆232), lacking the first 232 amino acids (25), and the full-
length APE1 have been previously described (26). Full-length DNA polymerase b was 
cloned into a modified pET28 vector containing amino-terminal His6 tag, followed by a 
TEV cleavage site. After TEV cleavage, the amino terminus is extended by two extra 
amino acids (GH). It was purified by a similar protocol as previously described (27). 
Protein concentrations were determined by their estimated extinction coefficients at 280 
nm. 
Oligonucleotide Substrates 
DNA oligonucleotides were synthesized by commercial sources using standard 
phosphoramidite chemistry and were purified and annealed as described (28). The 
sequence of 5’-fluorescein (FEM)-labeled oligonucleotide was 5’-FAM-
CGATAGCATCCTXCCTTCTCTCCAT, in which X was either a normal nucleotide or 
damaged nucleotide. The labeled oligonucleotide or damaged nucleotide. The labeled 
oligonucleotide was annealed with a 24-mer complement to create a single nucleotide 
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bulge, or with a 25-mer complement to create a central base pair (X•Y; Appendix Figure 
A-1). 
Glycosylase Assay in Whole Cell Extracts  
Glycosylase reactions were monitored at 37oC in a buffer containing 50 mM 
NaHEPES (pH 7.5), 100 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 0.1 mg/mL of 
bovine serum albumin, and 10% (v/v) glycerol. Reactions (20 µL) contained 10 nM 
FAM-labeled substrate and 3 µL aliquots were removed at the desired time points and 
quenched with 2 volumes of 0.3 M NaOH to obtain a final concentration of 0.2 M. AP 
sites formed from glycosylase reaction were quantitatively converted to DNA breaks by 
heating at 70oC for 15 min, followed by the addition of 3.3 volumes of formamide/EDTA 
loading buffer containing 0.05% (w/v) of bromphenol blue and xylene cyanol FF dyes. 
Samples were separated via denaturing PAGE and FAM fluorescence was quantified by 
imaging with a Typhoon trio (GE Healthcare) using 488nm excitation and a 520BP40 
emission filter. Flourescence intensity of individual bands was determined with 
ImageQuantTL (GE Healthcare). The fraction of glycosylase product was determined by 
dividing the fluorescence intensity of the 12-mer product band by the sum of the 12-mer 
product and 25-mer substrate bands. The fraction was converted into concentration by 
multiplying by the total amount of DNA substrate present. Reactions were carried out in 
triplicate and the initial rates were measured by a linear fit. To confirm the identity of the 
12-mer reaction product, we generated the authentic 12-mer from a single turnover 
reaction with 2 mM AAG and 10 nM I•T DNA. The reaction was quenched with NaOH 
after 15 min and treated as described above. Whole cell extracts (WCE) were obtained 
from Active Motif and were stored at -80oC in lysis buffer (20 mM NaHEPES pH 7.5, 
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350 mM NaCl, 20% glycerol, 1% Igepal-CA630, 1 mM MgCl2, 0.5 mM EDTA, 0.1 mM 
EGTA) until immediately before use. 
Inhibition of U-bulge glycosylase activity was achieved by addition of 0.02 units 
of uracil glycosylase inhibitor (New England Biolabs) to 0.4 mg/mL HeLa WCE as 
described above. Inhibition of the glycosylase activity toward I-bulge and eA bulge bulge 
DNA (10nM) was investigated by adding 100nM unlabeled 25-mer competitor DNA that 
was wither damaged (eA•T) or undamaged (A•T). To estimate the amount of AAG 
present in extracts, the standard glycosylase assay was performed with either 0.2 or 0.4 
mg/ml of WCE, 10nM I•T-labeled substrate, and 100nM A•T unlabeled DNA. The 
glycosylase activity of T47D and HeLa toward the I•T substrate was linearly dependent 
on the amount of extract added (supplemental Fig. S6). 
Alkylation of DNA by Chloroacetaldehyde 
A coupled assay was employed to determine the susceptibility of a bulged base to 
alkylative damage from chloroacetaldehyde. 1 µM A•T or A-bulge oligonucleotide as 
indicated was incubated at 37˚C in 50 mM Na2HPO4 (pH 7.5), and 100 mM NaCl. 100 
mM Chloroacetaldehyde (Sigma) was added as indicated. Reactions (4 µL) were 
incubated for 4 h at 37˚C, followed by the addition of 50 µL TE buffer (10 mM Tris, pH 
8.0, 1mM EDTA) and 50 µL of hydrated diethyl ether. The organic layer was removed 
and a second ether extraction step was performed. DNA was precipitated by the addition 
of 150 μL of cold ethanol, 0.12M sodium acetate. Samples were incubated for 30 min at -
80˚C and centrifuged for 15 min. After removal of the supernatant, samples were washed 
with 0.5 mL of 95% ethanol and centrifuged for 10 min. The supernatant was removed 
and the samples were air-dried. The εA lesions that were formed by alkylation of the 
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DNA were subsequently removed b AAG, which was found to have the same level of 
activity toward an εA-T mismatch as toward and εA-T bulge (data not shown) Samples 
were resuspended in 20 µL of AAG reaction buffer, 50mM NaMES (pH 6.1), 100 mM 
NaCl, 1 mM EDTA, 1 mM dithiothreitol, and 0.1 mg/mL bovine serum albumin, and 
incubated with 2 µM AAG at 37oC for 30 min. Samples were quenched in NaOH and 
analyzed by the standard glycosylase assay. 
BER Assay in WCE 
Assays for the processing of labeled mismatched and bulge DNA in were 
performed at 37oC in a 50 mM NaHEPES (pH 7.5), 100 mM NaCl, 5 mM MgCl2, 4nM 
ATP and 25 µM of each dNTP. Typically 10nM unlabeled (A•T) DNA were incubated 
with 0.4mg/ml of extract (Active Motif) in a reaction volume of 20 µL. Samples were 
taken by quenching 3 µL aliquots into an equal colume of formamide with 20nM EDTA, 
heated to 70oC for 5 min, and separated by denaturing PAGE. AP sites remained intact 
during this procedure. The amount of repair that had occurred was determined by 
quenching reactions with EDTA (10mM final). Recombinant AAG (2 µM) was added 
and reaction were incubated at 37 oC for 30 min. Finally, these reaction were quenched in 
0.2M NaOH and processed ad described above to cleave abasic sites.  
In Vitro BER Reconstitution 
Recombinant human proteins were used to reconstitute BER activity on either an 
I•T mismatch or an I-bulge. Reactions were incubated at 37˚C under that standard 
conditions of 50 mM HEPES (pH 7.5), 100 mM NaCl, 5 mM MgCl2, 4 mM ATP, and 2.5 
µM dNTP. Reactions contained 300 nM DNA substrate with 30 nM of AAG, APE1, 
polmerase β, and ligase I, as indicated in a total volume of 20 µL. After 60 minutes the 
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BER reaction was complete, at which point 3 µL aliquots were quenched in 
formamide/EDTA and analyzed as described above. We used this same protocol to 
follow the time course for multiple turnover BER activity, except that reactions contained 
700nM DNA and the putative physiological concentration (29) of APE (120nM), 
polymerase β (20nM) , and ligase I (40nM). 
RESULTS 
Glycosylase-Catalyzed Excision of Bulged Nucleotides in HeLa WCE 
 Oligonucleotide duplexes were incubated in human WCE to test whether DNA 
glycosylases can excise unpaired nucleotides (Figure 2-2A). These oligonucleotides were 
25 base pairs in length, with the central nucleotide unpaired (i.e. presented as a single 
nucleotide bulge). In addition to the four natural nucleotides, we also tested some 
common deaminated or alkylated nucleotides that are know to be present in chromosomal 
DNA. Deamination of C gives rise to uracil (U), deamination of A yields inosine (I), and 
alkylation of A can yield 1,N6-etheno-A (εA). Glycosylases do not require Mg2+ ions for 
activity, therefor we included EDTA in the glycosylase assay buffer, in the absence of 
Mg2+, most endonuclease and exonuclease activities were blocked and oligonucleotides 
remained intact for greater the 24h (Figure 2-2B). 
There was no detectable glycoslyase activity toward undamaged nucleotides in 
single nucleotide bulges in HeLa WCE (Figure 2-2B, lanes 1-8). This could be due to 
extremely low tares of excision of natural nucleotides by human DNA glycosylases or the 
protection of these sites by other proteins present in the extract. In contrast, damaged 
nucleotides were rapidly excised (Figure 2-2B, lanes 9-14). Significant excision was 
detected at 1h, with complete processing of the bulge occurring with in 24h. If reactions 
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were quenched in formamide, instead of hydroxide, the 12-mer product was not 
observed. This confirmed that all three damaged nucleotides were excised by 
monofunctional DNA glycosylase (Appendix Figure A-2). Initial rates of base excision in 
the HeLa extracts show that the U-bulge was most rapidly removed (Figure 2-2C). The I-
bulge was removed at a 4-fold slower rate and the εA-bulge was removed at a 20-fold 
slower rate than the U-bulge. We next sought to identify the enzymes responsible for this 





Figure 2-2. Human glycosylases excise alkylated and deaminated bases, but not undamaged bases, 
from one-nucleotide bulges. (A) DNA glycosylase activity was monitored in HeLa WCE using 
fluorescently labeled oligonucleotides that contained single nucleotide bugles. AP products were 
cleaved under alkaline conditions and samples were analyzed by denaturing PAGE. (B) A 
representative gel is shown. Undamaged (lanes 1-8) and damaged (lanes 9-14) DNA (10nM) was 
inclubated in 0.4 mg/ml of WCE for the indicated time. An I-T substrate was incubated in the 
presence or absence of recombinant AAG to provide size standards for the 25-mer intact substrate (S) 
and the 12-mer glycosylase generated product (P). (C) Initial rate for excision of damaged nucletides 
present in single nucleotide bulges were determined as described above. The mean standard deviation 
is shown from 3 independent experiments. 
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Identification of DNA Glycosylase Acting at Bulged Nucleotides – There are four human 
glycoslyases that are known to excise U from DNA (30). The most active of these is 
uracil DNA glycosylase (UDG) (31). UDG is inhibited with high affinity and specificity 
b the bacteriophage-encoded UDG inhibitory protein (UGI), therefore we tested if UGI 
would block the excision of a U-bulge in HeLa WCE (32). Complete inhibition was 
observed, demonstrating the UDG was the glycosylase responsible for acting on a U-
bulge.  
We expected that the I and εA-specific activities would both be attributed to 
alkyladenine DNA glycosylase (AAG), because this is the only human enzyme known to 
excise alkylated and deaminated purines from DNA (33-36). εA is formed by 
endogenous reactive species resulting from lipid peroxidation (37). Vinyl choloride 
exposure caused increased levels of εA via the P450 catalyzed production of 
chloroethylene oxide and chloroacetaldehyde (37, 38). AAG is the only protein found to 
bind εA•T DNA in cell extracts from human tissues (39, 40) and it binds with very high 
affinity (41). Therefore, we tested if unlabeled εA•T DNA inhibits the excision of I and 
εA from single nucleotide bulges. As expected, the addition of 10-fold excess εA•T 
decreased the excision of εA from the bulge to undetectable levels, whereas undamaged 
competitor DNA (A•T) had no effect (Figure 2-3B). Similarly, the εA•T competitor 
completely blocked activity toward and I-containing single nucleotide bulge. This 
suggests that AAG is responsible for the excision of alkylated and deaminated purines 
present in a single nucleotide bulge.  
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Bulges containing damaged nucleotides can be formed when a DNA polymerase 
encounters a bulky lesion, such as εA, on the template strand. The Y-family polymerases 
are particularly prone to template slipping. For example, frequent -1 slips are observed 
during replication of εA –DNA by human polymerases μ, κ, and η (43, 44) and during 
replication of εG-DNA by Dpo4 (45, 46). However, other types of damaged nucleotides 
are not known to induce polymerase slipping. For these types of damage, which includes 















Figure 2-3. Deaminated bulged bases are excised by UDG and AAG. Glycosylase assays in HeLa 
cell extracts were performed as described in the legend to Figure 2-2. (A) U-bulge DNA was 
incubated in the presence or absence of UGI (0.02 units). UGI completely blocks U-bulge 
glycosylase activity, demonstrating that UDG is the enzyme responsible. (B) Fluorescently labeled I-
bulge or εA-bulge DNA was incubated with no competitor DNA (-), undamaged DNA (A-T), or 
damaged DNA (εA-T) for 24 h. AAG is the only human glycosylase known to excise εA lesions, 
therefore the strong competition by εA-containing DNA suggests that AAG is responsible for both 
activities. 
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Unpaired Nucleotides are More Susceptible to Damage  
Single nucleotide bulges formed by polymerase slipping events are more exposed 
than Watson-Crick paired nucleotides (47, 48), suggesting thea bulged nucleotides would 
also be damaged by oxidation and alkylation. We tested whether a bulged A is more 
susceptible to alkylative damage than an A•T base pair. As described above, alkylation of 
DNA by chloroacetaldehde results in the formation of a variety of alkylation adducts, 





Figure 2-4. Single nucleotide bulges are highly susceptible to alkylation damage. (A) 
chloroacetaldehyde (CAA) reacts A nucleotides in DNA to produce the alkylation adduct εA. Sites 
of εA formation were detected by the glycosylase activity of AAG. (B) Stably paired (A-T) or a 
single nucleotide A-bugle was incubated with chloroacetaldehdye (100mM) for 4 h. After AAG-
catalyzed excision of εA lesions alkaline hydrolysis of AP sites, samples were analyzed by 
denaturing PAGE. Only the A-bulge showed detectable εA formation under these conditions. 
Quantification of duplicate experiments revealed that 18% of the A-bugle is alkylated. This 
indicates that the A-bulge is at least 18-fold more reactive than an A-T pair. 
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We exposed a fully paired duplex (A•T) and a single A-bulge to a high 
concentration of chloroacetaldehyde (100nM) for 4h. Excess alkylating agent was 
removed and the DNA was incubated with recombinant AAG in the standard glycosylase 
assay. Both alkylating agent and AAG were required to get the specific 12-mer product 
resulting from the glycosylase reaction at this bulged site (Figure 2-4). Additional 
experiments showed that this alkylation reaction is dependent upon the concentration of 
chloroacetaldehyde and on the amount of time that DNA was exposed (Appendix Figure 
B-4). We observed that the bulged A has >18-fold increased reactivity to a paired A 
(Figure 2-4 and Appendix Figure B-4). 
Deletion of an I-Bulge in Cell Extracts 
Above we demonstrated that DNA glycosylases catalyze the excision of lesions 
from a single nucleotide bulge to create a bulged AP site. If this intermediate can be 
processed b the major human APE1, then the BER pathway, including dNTPs, ATP and 
Mg2+, to HeLa WCE to test if the predicted one nucleotide deletion could be detected 
with either an I-bulge or a U-bulge substrate. Under these conditions, we observed a 
variety of BER intermediates that were consistent with the processing of these 
deaminated single nucleotide bulges by BER (Appendix Figure B-7). However, we 
observed a substantial level of 3’-5’ exonuclease activity in HeLa WCE that degraded in 
DNA oligonucleotides even when the BER pathway was inhibited. It should not be noted 
that this exonuclease activity is an artifact of using short oligonucleotides substrates and 
is not expected to play a role when bulged nucleotides are present in chromosomal DNA. 
This exonucleolytic activity could be decreased by adding unlabeled competitor DNA 
(undamaged A•T 25-mer), presumably by providing additional DNA ends that would be 
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substrates for the hydrolytic enzyme(s). We infer that there was insufficient glycosylase 
activity for the BER pathway to fully outcompete the degradation pathway(s) in HeLa 
WCE when short oligonucleotides are used as substrates. Therefore, we investigated 
several additional human cell lines in which the balance of BER and exonucleolytic 
degradation might differ. 
Many cancer cell lines, especially breast cancers, have increased AAG expression 
(49, 50). We chose one of these cell lines (T47D), a ductal breast tumor, because AAG is 
reported to be expressed at a 3-fold higher level relative to HeLa cells (50). We first 
measured the level of glycosylase activity toward an I•T mismatch in HeLa and T47D 
WCE and confirmed the 3-fold higher level of AAG activity in T47D (Appendix Figure 
B-5). We next estimated the repair of I•T and I-bulge DNA in T47D extracts under the 
BER conditions. The I•T mismatch was processed to build up a nicked DNA intermediate 
(Figure 2-5A). The presence of the repaired 25-mer product was confirmed by treating it 
with excess recombinant AAG and alkaline cleavage, which fully cleaved any remaining 
lesion-containing DNA (Figure 2-5B, lane 2). In the case of the I-bulge, a new 24-mer 
product was formed (Figure 2-5B, lanes 5-8) that was similarly resistant to cleavage by 
recombinant AAG (Figure 2-5B, lane 4). This suggests that WCE are capable of 
catalyzing a single nucleotide deletion with and I-bulge on a similar time scale to repair 
of an I•T mismatch. When εA•T competitor was added there was no repair of the I•T or I-
bulge (Figure 2-5B, lanes 5-8). We also noticed small amounts of polymerase extension 
products under these conditions. These products were greatly reduced by aphidicolin, an 
inhibitor of polymerase μ, κ, and η, and did not occur if dNTPs were omitted from the 
reaction (Appendix Figures B-10 and B-11). 





Figure 2-5. Base excision repair assays in T47D WCE demonstrates single nucleotide deletion. 
Conditions were similar to those in Figure 2-2, but 5 mM MgCl2, 1 mM ATP, and 0.1 mM 
of the four dNTPs were added to support BER activity. The expected single nucleotide 
deletion product (24mer) was detected within 30 minutes. The I•T mismatch was processed 
on the same time scale, as evidence by the build-up and disappearance of BER 
intermediates. No BER intermediates or deletion products were observed when εA•T-
containing unlabeled competitor DNA was included in the incubation.(B) Determination of 
extent of repair for reactions shown in (A). After 120 min samples were split and either 
incubated with recombinant AAG (+AAG) to process the remaining I lesions, or 
immediately quenched in formamide/EDTA (-AAG). Alkaline hydrolysis of the abasic site 
occurs via β,δ-elimination to generate a 3’-phosphate (3’-P), making it possible to quantify 
the amount of I lesion present after incubation in WCE. In contrast, the APE1-catalyzed 
reaction in the extract yields a 3’-hydroxyl (3’-OH). The persistent 25-mer in lane 2 and 24-
mer in lane 4 confirms that the I lesion was removed. 
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This proposed single nucleotide deletion of a bulged lesion is depicted in Figure 
2-6, by analogy to the normal BER pathway. Only the short patch pathway is shown, but 
long patch BER with strand displacement, flap cleavage by FEN1, and ligation will also 
form the single nucleotide deletion. The key steps are initiation of the pathway by a DNA 
repair glycosylase, as we have shown for AAG and UDG, and the subsequent hydrolysis 
of the abasic bulge by APE1, as shown below, or by AP lyases (data not shown). To 
	  
	  
Figure 2-6. Proposed single nucleotide deletion pathway catalyzed by BER enzymes. The BER 
pathway for AAG-initiated short patch is shown on the left and the proposed pathway for single 
nucleotide deletion is shown on the right. Note that only the glycosylase and endonuclease 
reactions differ for the two pathways. After APE1 cleavage the 5’dRP intermediate is chemically 
identical to the intermediate generated after single nucleotide incorporation in the short-patch BER 
pathway. 
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confirm the proposed pathway and to evaluate the relative rate of single nucleotide 
deletions we employed in vitro reconstitution using recombinant human proteins. 
 
 
Reconstitution of Single Nucleotide Deletion by Enzymes of the Short Patch BER 
Pathway 
 
We examined steady state multiple turnover repair reactions of either an I•T 
mismatch or an I bulge under the standard BER assay conditions with the putative 
physiological levels of the human proteins, AAG, APE1, pol b, and DNA ligase I (43). A 
	  
 
Figure 2-7. Time dependence of repair demonstrates that the single nucleotide deletion 
pathway occurs at the same rate as the BER pathway. A, multiple turnover reconstituted BER 
reactions contained 700 nM I mismatch or bulge DNA, 70 nM AAG, 120 nM APE1, 20 nM pol b, 
and 50 nM DNA Ligase I and the necessary nucleotide and Mg2+ cofactors (see Methods for 
details). Reactions were quenched at the indicated time with formamide/EDTA loading buffer and 
analyzed by denaturing PAGE. B, the level of the 12mer nicked DNA intermediate was quantified 
from 3 independent experiments and the mean ± SD is shown. 
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representative time course is shown in which reactions were quenched in 
formamide/EDTA and analyzed by denaturing PAGE (Figure 2-7). An early time point 
confirms that this quench is sufficient under these conditions (lane 1 & 6). Within 5 
minutes a nicked DNA intermediate could be detected that builds up and breaks down, so 
that by 60 minutes the repair is complete (corresponding to ≥10 turnovers). The 
quantitative conversion to a single nucleotide deletion product (24mer, lane 10) 
demonstrates that all enzymes are active and we infer that the 25mer species in the repair 
of the I•T mismatch is the corrected A•T product. Quantification of the nicked DNA 
intermediate generated with a mismatch and with a bulge indicates that both substrates 
are repaired with similar rates (Figure 2-7B).  
 
 
Figure 2-8. In vitro reconstitution of the single nucleotide deletion pathway with recombinant 
human BER proteins. Recombinant human AAG, APE1, pol β, and DNA lig I were both 
necessary and sufficient for the single nucleotide deletion in vitro (lane 2), and omission of any 
single protein gave the expected product (Figure 2-5). Note that the abasic intermediate migrates 
between the 25mer substrate and the 24mer product (lane 4) and the omission of DNA ligase (lane 
5) leads to some strand displacement by DNA pol β.	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To confirm that these four proteins are necessary and sufficient for the single 
nucleotide deletion (Figure 2-7), we omitted each protein in turn (Figure 2-8). After an 
hour incubation the single nucleotide deletion was complete (lane 2). No detectable 
reaction occurred in the absence of AAG (lane 3), whereas the omission of APE1 led to 
the abasic DNA intermediate with slightly increased mobility (lane 4). This is consistent 
with the extremely weak AP lyase activity of pol β (44). In the absence of pol β, the 
bulged substrate was processed to a single strand nick, the ligation of which is blocked by 
the 5’dRP group (lane 5). Finally, omission of DNA ligase I prevented DNA ligation. In 
the absence of ligase, pol β incorporates an additional nucleotide (lane 6). These 
experiments demonstrate that the human BER enzymes efficiently catalyze the deletion 
of a damaged nucleotide bulge, and that this reaction occurs on the same time scale as the 
well-characterized short patch BER pathway for the repair of damaged nucleotides 
present as a mismatch (Figure 2-8). 
DISCUSSION 
 
Previous reports that imbalanced levels of BER enzymes increase the frequency 
of frameshift mutations (24,25) led us to test if the BER pathway acts on single 
nucleotide bulges. Such bulges can occur by a variety of mechanisms (Figure 2-1). Using 
cell extracts and reconstitution with recombinant proteins, we show that deaminated and 
alkylated nucleotides present in single nucleotide bulges are good substrates for BER, 
resulting in rapid deletion of the damaged nucleotide. These observations suggest that 
competition between repair pathways can affect the frequency of frameshift mutations. 
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Glycosylases Excise Damaged Nucleotides Present in Single Nucleotide Bulges 
We identified UDG and AAG as two glycosylases that efficiently recognize base 
lesions presented as a single nucleotide bulge. The activity of UDG was not too 
surprising, because it has robust activity towards U in both single- and double-stranded 
DNA. In contrast, the activity of AAG towards I in a single stranded substrate is ~103-
fold lower than towards I in a double stranded substrate. We have used single turnover 
kinetics to show that AAG has a 3-fold preference for an I bulge over an I•T mismatch 
(31). These observations demonstrate that the UDG and AAG active sites are very 
flexible and able to recognize their substrate nucleotides in very different contexts. 
Similar to UDG, two human homologs of E. coli EndoVIII , NEIL1 and NEIL2, 
show substantial activity towards oxidized bases in single-stranded DNA (45). NEIL2 has 
~5-fold greater activity towards a lesion present in a single nucleotide bulge than the 
same lesion in single-stranded DNA (46). Other DNA glycosylases show much stronger 
preference for duplex substrates, including a recently characterized glycosylase from M. 
tuberculosis. In initial experiments this enzyme was shown to excise U from a single 
nucleotide bulge, albeit at a reduced level of activity relative to U in a mismatch (47). 
Several glycosylases use specific recognition of the opposing base to ensure high fidelity 
repair. For example, MutY and its human homolog excises an A preferentially from an 
A•8-oxoG pair and OGG1 excises 8-oxoG from an 8-oxoG•C pair. On the one hand, this 
specific recognition may prevent these glycosylases from accepting single nucleotide 
bulges. On the other hand, a single nucleotide bulge may be more easily flipped by the 
enzyme. 
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There was no detectable glycosylase activity towards normal nucleotide bulges in 
HeLa cell extracts under multiple turnover conditions. However, it has previously been 
shown that AAG exhibits low levels of activity towards the normal nucleotides A and G, 
and this activity is greater when they are present in a mismatch (19,21). Under single 
turnover conditions we found that AAG has similar activity towards undamaged purines 
as towards purines present in a mismatch (data not shown). Therefore, in MMR deficient 
cells there is the possibility that AAG could act directly on bulged sites resulting from 
DNA replication. This would serve to bias frameshift mutations to -1 events, because 
both daughter cells would be corrected in the case of +1 slipping events and both 
daughter cells would be mutant in the case of -1 slipping events. A more likely scenario 
is that spontaneous damage to a bulged nucleotide would generate a good substrate for 
BER. 
Bulged nucleotides are more susceptible to damage 
The reactivity of single nucleotide bulges have not been extensively 
characterized. However, the nucleobases of single stranded DNA are much more reactive 
those in duplex DNA towards a variety of types of damage. For example, deamination of 
C to U occurs ~100-fold faster in single stranded DNA than in duplex DNA (48,49). It 
has also been noted that C mismatches have elevated spontaneous deamination rates 
relative to C•G pairs, and in some sequences the rates of deamination of the C mismatch 
approaches that of single stranded DNA (50). Here we have tested the reactivity of a 
bulged A towards a DNA alkylating agent. Under the conditions tested, 
chloroacetaldehyde has more than 15-fold greater reactivity towards the single nucleotide 
bulge relative to a stably paired nucleotide in the same sequence context (Figure 2-4). 
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The greater reactivity of a single nucleotide bulge towards endogenous and exogenous 
forms of base damage underscores the importance that polymerase slippage be corrected 
quickly. 
Human BER Excises Damaged Nucleotides Present in Single Nucleotide Bulges 
We tested whether the BER pathway can process glycosylase-initiated bulged 
abasic sites in human cell extracts to effectively delete the damaged nucleotide. In 
extracts from a human breast cancer cell line (T47D), we observed the expected single 
nucleotide deletion product (Figure 2-5). The most persistent intermediates are consistent 
with the short patch BER pathway, whereas some intermediates can be detected that 
would correspond to the long patch BER pathway. Both pathways give the same single 
nucleotide deletion. To further test the proposed model, we reconstituted the pathway 
using recombinant proteins (Figures 2-7 and 2-8). This confirms the proposed pathway 
(Figure 2-6) and demonstrates that APE1 efficiently processes a bulged abasic site. 
Abasic site recognition by APE1 involves flipping of the abasic site into the active site 
pocket where endonucleolytic cleavage 5’ of the abasic site can take place (51). APE1 is 
able to process abasic sites in single stranded DNA (52) and it can also catalyze 
endonucleolytic cleavage at bulky lesions, such as a-anomeric nucleotides (53). The 
finding that APE1 acts on a single nucleotide bulge is further evidence for a great 
flexibility in substrate recognition.  
It has recently been demonstrated that Neil1, a bifuctional DNA glycosylase/AP 
lyase, is able to perform both glycosylase and lyase activities on a single nucleotide bulge 
(46). In this case the action of polynucleotide kinase 3’phosphatase is required to 
generate a ligatable nick (46,54). 
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Competition for Repair of Bulged Nucleotide Intermediates 
Our model for BER-mediated frameshift mutations is illustrated in Figure 2-9. In 
Figure 2-9A, replication across a lesion can allow for polymerase bypass producing a 1-nt 
slipping error and a damaged, bulged nucleotide product. MMR provides high fidelity 
repair of bulged intermediates, however, BER activity would resolve the bulge to a 1-nt 
deletion. One example in which this model is likely to take place is in the replication of 
abasic sites. If an abasic template is encountered, then it is know that pol β will, with high 
frequency, slip past. We propose it does this by first generating a bulged abasic site that is 
subsequently processed by APE1, pol β and either DNA ligase I or DNA ligase III. This 
could nicely account for the finding that overexpression of pol b gives rise to greater 




Figure 2-9. Model for competition between MMR and BER in the processing of nascent 
frameshift mutations.  An example is shown in which a polymerase slips on an undamaged 
homopolymeric run, resulting in a -1 or +1 event (See Figure 2-1 for alternative mechanisms by 
which bulged intermediates are formed). Subsequent damage allows it to be recognized by BER, 
which will repair a +1 event but make a -1 event permanent. MMR provides a high fidelity 
pathway for repairing either -1 or +1 events, but imbalances in MMR or BER is expected to 
increase the frequency of frameshift mutations.	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Alternatively, a polymerase could slip on an undamaged template to give rise to 
an undamaged bulge. MMR can repair both -1 and +1 slips to prevent these from 
becoming frameshift mutations. However, if the bulge remains undetected then it is 
susceptible to DNA damage. We have shown that for at least some types of oxidative and 
alkylative damage, BER can potentially compete with MMR. This competition will favor 
BER if there is a high burden of DNA damage or if the levels of repair activities are 
imbalanced (i.e., depletion of MMR enzymes or overexpression of BER enzymes). In the 
case of a nascent +1 slip, this cycle of damage and deletion via BER would restore the 
original DNA sequence. However, a nascent -1 slip would be converted into a -1 
frameshift and would no longer be available to another pathway such as MMR. 
Consistent with our hypothesis, there is abundant evidence that human cancer 
cells show a strong preference for -1 versus +1 frameshifts. Most directly, Samson and 
coworkers demonstrated that overexpression of AAG in yeast leads to a 30-fold increase 
in the frequency of -1 frameshifts at an A tract site (24). This observation is not easily 
explained by the established models of low fidelity BER initiated at normal sites, but is 
fully consistent with the model proposed herein. Intriguingly, several studies found AAG 
over-expression gives rise to increased mutation rates. AAG expression is commonly up-
regulated in breast cancers and previous studies have found that these same cell lines 
exhibit elevated levels of -1 frameshift mutations, in addition to elevated levels of point 
mutations. A large body of work suggests that imbalanced BER can lead to increased 
frequency of point mutations, presumably due to errors in lower fidelity polymerases or 
two errors in replicating a repair intermediate. Our studies provide a plausible model to 
account for frameshift mutations under the situation of imbalanced BER. 
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Figure A-1. Sequence of oligonucleotides that were used in this study. X position is varied 
between normal and damaged bases and contains a 5’-fluorescein attached by a 6-aminohexyl 




Figure A-2. (A) Monitoring of glycosylase activity on 10nM I-bulge substrate in 0.4 
mg/mL HeLa WCE under glycosylase conditions produces a hydroxide cleavable abasic 
site and the resulting 12mer product. Simultaneous quenching with formamide/EDTA 
shows that the abasic site largely remains intact under these conditions, producing a small 
amount of enzymatic cleavage after two hours. This activity is likely due to lyase activity 
by bifunctional glycosylases. (B) Quantification of nicked intermediate (12mer). 
	  

































































Figure A-3. Quantification of AAG excised CAA alkylation of 100nM DNA at the 
12mer position from Figure 4 (lanes 3 and 6). Data is an average of three experiments 




Figure A-4. Concentration and time dependence of chloroacetaldehyde (CAA) 
alkylation of A•T and A-bulge substrates was performed under similar conditions as 
Figure 4. 500nM DNA in a 50μL reaction volume was incubated with CAA for the time 
and concentration of CAA indicated. CAA was extracted twice with hydrated ether 
without a subsequent ethanol precipitation. 4μL of the CAA damaged DNA was incubated 
with 2μM AAG for 30 min at 37 °C in a 20μL reaction volume. Samples were analyzed 
according to the standard glycosylase assay.  
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Figure A-5. Initial rates of AAG activity on 10nM I•T substrate under 
glycosylase conditions at two concentrations of HeLa and T47D WCE as 
represented in Figure 5. Each point represents the average of three experiments with 




Figure A-6. Base excision repair assay performed in 0.4 mg/mL HeLa WCE with 10nM 
U-bulge substrate and 100nM unlabeled A•T DNA competitor. Production the expected 
nicked intermediate (12mer) from U-bulge substrate appears to be further processed by BER to 
produce polymerase extension intermediates. No BER intermediates were observed when 
UDG glycosylase activity was inhibited by 0.02 units of UGI, but 3’-5’ exonuclease 
degradation is apparent.  
	  



































































Figure A-7. Base excision repair assay performed in human colon adenocarcinoma nuclear 
extract. Under same conditions as Figure 6, 0.4 mg/mL HT-29 NE produces the expected nicked 
intermediate (12mer) that appears to be processed to the deletion product (24mer). No BER 
intermediates were observed when inhibited by unlabeled εA•T competitor, but 3’-5’ exonuclease 
degradation is apparent. 
	  














Figure A-8. Base excision repair assay performed in human breast ductal carcinoma 
nuclear extract, under conditions described for observing BER acitivty. 0.4 mg/mL MCF7 
NE produces the expected nicked intermediate (12mer) from I-bulge substrate that is processed 
to the deletion product (24mer). Reaction contained 10-fold excess unlabeled A•T DNA 
competitor. 
	  












EFFICIENT RECOGNITION OF AN UNPAIRED LESION BY A DNA REPAIR 
GLYCOSYLASE 
 
The double-helical structure of DNA protects the nucleobases from oxidative and 
alkylative chemical damage [1]. However, this internal base pairing is also a barrier to the 
enzymes that recognize and repair DNA damage [2]. Enzymes that modify bases in DNA 
use nucleotide flipping to rotate the target nucleotide out of the duplex into an active site, 
but the energetic barrier that must be overcome is not fully understood. Unpaired 
(bulged) nucleotides are more accessible, but it is not know to what extent they are 
recognized by nucleotide-flipping enzymes. We have investigated this question with 
human alkyladenine DNA glycosylase (AAG). AAG recognizes a wide variety of 
structurally disparate lesions, including deoxyinosine (I), which results from the oxidative 
deamination of adenosine. AAG catalyzes the hydrolysis of the N-glycosidic bond to 
release the lesion base and initiate the base excision repair pathway (Figure 3-1A) [3]. 
We used single-turnover kinetics to demonstrate that AAG is exquisitely sensitive to the 
structural context of the I lesion. An inverse correlation between duplex stability and 
catalytic efficiency was observed, indicating that stable pairing is a barrier to recognition  
Reproduced with permission from Lyons, D.M., and O’Brien, P.J. (2009) Efficient Recognition of an 
Unpaired Lesion by a DNA Repair Glycosylase, Journal of the American Chemical Society 131(49):17742-
3. Copyright 2009 American Chemical Society. 
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by AAG. Single-stranded DNA is a very poor substrate, but a single-nucleotide bulge is  
recognized more efficiently than any other context. These results highlight the intrinsic 
barrier to nucleotide flipping that DNA repair enzymes face and imply that the 
recognition of DNA damage by AAG is remarkably plastic. 
 
Crystal structures of AAG bound to an extrahelical lesion reveal that the DNA is 
bent, the lesioned base is rotated by ~180o out of the duplex into the active site pocket, 
and the hole that is left in the DNA is plugged with the phenolic group of Y162 (Figure 
3-1B) [4]. Intimate protein-DNA contacts in this static structure seem to preclude the 
possibility that a bulge could be accommodated. However, the barrier to flipping of a 
bulged nucleotide is much less than that for a mismatch. Bulged purines favor an 
	  
	  
Figure 3-1. Deamination of A to form I and the structure of AAG bound to damaged DNA. 
(A) Oxidative deamination of A is reversed by AAG and the base excision repair pathway. (B) 
AAG is red, the intercalating tyrosine (Y162) is magenta, and the DNA is blue, except for the 
lesion (yellow) that is flipped into the active site and the opposing nucleotide (black). This 
opposing nucleotide is missing in the bulged substrate. Coordinates are from the Protein Data Bank 
structure for AAG bound to 1,N6-ethenoA-DNA (PDB entry 1EWN). 
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intercalated conformation, but an extrahelical conformation has been observed in a 
crystal structure [5, 6]. If AAG has sufficient flexibility to encompass a bulged 
nucleotide, then the decreased barrier to flipping would enable more efficient recognition.  
Therefore, we characterized the activity of AAG toward an I lesion in different 
structural contexts, including a single-nucleotide bulge. Product release is rate-limiting 
for multiple turnover reactions of AAG, requiring the use of single-turnover methods [7, 
8]. The concentration of AAG was varied to determine the maximal single turnover rate 
constant (kmax) and the half-maximal concentration (K1/2) for each context (Figure 3-2). 
Although the individual reaction rates varied by more than 10,000-fold, with half-times 
that varied from seconds to days, single-exponential fits were excellent in all cases 
(R2>0.97; see the Supporting Information for representative data). The rate constant kmax 
reports on the flipping and N-glycosidic bond hydrolysis steps, and the K1/2 value 
	  
	  
Figure 3-2. Concentration dependence for single-turnover glycosylase activity of AAG. Each data 
point corresponds to the average and standard deviation from 4-8 individual reactions (see the 
Supporting Information). Lines indicate the best fits to a hyperbolic concentration dependence: kobs ) 
kmax[AAG]/(K1/2 + [AAG]).  
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corresponds to the Kd for substrate dissociation.6 The specificity between competing 
substrates is given by the ratio kmax/K1/2, the catalytic efficiency (analogous to kcat/KM in 
steady-state kinetics). 
 
The glycosylase activity of AAG is shown in Figure 3-2 and summarized in Table 
3-1. The bulge was the best context tested, with a catalytic efficiency that is 3-fold better 
than that for the biological I•T mismatch. This result indicates that the increased ease in 
flipping the lesion more than compensates for any unfavorable effects of removing the 
opposing base (Figure 3-1B). Further work is needed to evaluate whether the bulge might 
be more easily bent than the mismatch and whether this could contribute to catalytic 
recognition. Other mismatches were recognized less efficiently than the I•T mismatch. 
The single-stranded lesion is even more accessible, and several glycosylases efficiently 
utilize single-stranded substrates; however we found that AAG has ~2000-fold reduced 
activity toward this substrate. 
	  
	  
Table 3-1. Kinetic parameters for the AAG-catalyzed hydrolysis of inosine in different structural 
contexts. aData were obtained at 23C in 50mM NaMES (pH 6.1), 1mM DTT , 0.1 mg/mL BSA. The 
ionic strength was adjusted to 200mM with NaCl. bkmax/K1/2 is a measure of the catalytic efficiency, 
analogous to kcat/Km in steady-state kinetics. c This oligonucleotide does not appear to adopt secondary 
structure, because a single-stranded polyT oligonucleotide gave very similar kinetic parameters (see 
Appendix B). 
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Since AAG does not make specific contacts with the opposing base, the 
relationship between base-pair stability and catalytic efficiency for different mismatches 
can be assessed. Thermodynamic parameters for duplex stability for inosine paired with 
each of the normal nucleotides are known [9] and serve as a surrogate for base-pair 
stability. The relative free energies (∆∆G) for catalytic efficiency of the AAG-catalyzed 
reaction and for duplex stability are presented in Figure 3-3. A linear fit to all of the 
mismatches yields a slope of -0.96 (R2 = 0.67), and omission of the I•T substrate gives a 
slope of -0.59 (R2 = 0.97). This is a limited set of data, but the trend is clear. Previous 
analysis of the thermodynamics of duplex stability and DNA binding by uracil DNA 
glycosylase found that disruption of base pairing gives greater accessibility and tighter 
binding [10, 11]. The inverse relationship between duplex stability and efficiency of 
excision supports the model that AAG and other glycosylases 
 
Figure 3-3. Linear free-energy relationship showing an inverse correlation between duplex 
stability and glycosylase activity. Differences in free energy (∆∆G) are from ref 7 for duplex 
stability and from the equation ∆∆G ) -RT ln(kmax/K1/2rel) for AAG activity. Linear fits to all of the 
mismatches (dashed line; slope ) -0.97, R2 ) 0.67) and with the exclusion of the T mismatch (solid 
line; slope ) -0.59, R2 ) 0.97) are shown. The relative activity toward a bulge is shown as a dotted 
line.  
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 must overcome the barrier provided by base-pairing interactions. This behavior 
maximizes the discrimination between damaged and undamaged nucleotides because 
undamaged nucleotides have more favorable hydrogen-bonding and stacking interactions. 
The I•T mismatch deviate by ~1 kcal/mol relative to the other mismatches, raising 
the possibility that AAG recognizes the I•T wobble pair geometry independent of its 
effects on duplex stability. Indeed, I•G forms a less stable duplex than I•T and yet it is 
removed with 5-fold lower catalytic efficiency. Deamination of A in DNA generates an 
I•T pair, and AAG-initiated repair restores the correct sequence. Incorporation of dIMP 
or replication of an I lesion predominantly forms an I•C pair [12, 13]. Under these 
scenarios the activity of AAG would make a permanent mutation. The much lower 
efficiency of AAG towards I•C leaves open the possibility that another DNA repair 
pathway corrects replicative events. 
By quantifying the energetic differences in the catalytic efficiency of AAG with 
different mismatches, we obtained strong evidence that base pairing provides a barrier to 
base excision. The fact that a bulge is recognized with the same efficiency as a mismatch 
indicates considerable flexibility in DNA recognition. This also has biological 
ramifications, as DNA polymerases can slip on repetitive or damaged templates to 
generate bulged structures. Initiation of base excision repair could correct nascent +1 
frameshifts but would make -1 frameshifts permanent. This ability of AAG to act on 
bulged nucleotides may explain the observation that an increased level of AAG 
expression is correlated with increased frequency of frameshift mutations [14]. 
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MATERIALS AND METHODS 
Expression and Purification of Recombinant AAG.   
The catalytic fragment of AAG lacking the first 79 amino acids (∆80) was 
expressed in E. coli and purified as previously described.1 The truncated protein has a 
slightly decreased ability to translocate along DNA, relative to the full-length enzyme, 
but both proteins have identical glycosylase activity towards inosine and 1,N6-
ethenoadenosine lesions.2,3 The concentration of active enzyme was determined by burst 
analysis as described below and the concentration of active enzyme was used throughout. 
Oligonucleotide Substrates.  
The sequences and annealed structures of the DNA oligonucleotides used in this 
study are given in Figure S1. The lesion-containing 25mer oligonucleotides have a 
centrally located inosine lesion and includes a 5’-fluorescein (6-fam) label.  
Complementary strands are unlabeled. The DNA oligonucleotides were synthesized by 
commercial sources using standard phosphoramidite chemistry, and were purified by 
denaturing polyacrylamide gel electrophoresis on a 20% polyacrylamide gel (6.6 M urea 
and Tris-borate buffer; 89 mM tris, 89 mM borate, 2 mM EDTA).  Full-length 
oligonucleotides were excised from the gel, crushed, and soaked overnight in 500 mM 
NaCl and 1mM EDTA.  Desalting was accomplished by reverse phase chromatography 
(C18 Sep-pak, Waters).  Concentrations of single-stranded oligonucleotides were 
determined by absorbance at 260 nm using the calculated extinction coefficients.  For 
glycosylase assays, oligonucleotides were annealed with a 1.5-fold excess of 
complementary strand, heated to 90˚C and subsequently cooled to 4˚C over ~15 min.   
General Glycosylase Assay.  
Samples were quenched with two volumes of 0.3 M NaOH to obtain a final 
concentration of 0.2 M. Abasic sites were quantitatively converted to DNA breaks by 
heating at 70˚C for 15 min, followed by the addition of 3.3 volumes of formamide/EDTA 
loading buffer that contained 0.05% w/v of both bromophenol blue and xylene cyanol FF 
as tracking dyes.  DNA substrate (25mer) and cleaved product (12mer) oligonucleotides 
were separated on a 20% denaturing polyacrylamide gel containing 6.6 M urea.  A 
typhoon trio imager was used to scan the gels with a 488 nm excitation and 520 nm long 
pass filter to detect the fluorescein labeled oligonucleotides.  The substrate and product 
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bands were quantified with Image Quant TL (GE Healthcare) and the fraction product 
formed at each timepoint was calculated by [F = P/(P+S)], in which F is the fraction 
converted to product, P is the fluorescence of the product, and S is the fluorescence of the 
intact substrate. Control reactions in which enzyme was omitted revealed that inosine-
containing oligonucleotides were stable to this procedure and no product was detected in 
the absence of glycosylase. 
Burst Analysis to Determine Active AAG Concentration.  
The active concentration of recombinant AAG was determined by burst analysis 
as previously described.2 With a fixed concentration of 1µM of I•T 25mer substrate, 
which is far above the Kd, the concentration of AAG was varied to obtain a burst of 5-
20%. The fraction product was determined by polyacrylamide gel electrophoresis, as 
described above, and converted into concentration of product by multiplying by the 
concentration of initial substrate. The production of product followed an initial burst, 
followed by a slow multiple turnover rate. The reaction progress curve was fit by 
equation #1 using Kaleidagraph, in which P is product, A is the burst amplitude, kobs is 
the burst rate constant, and Vobs is the steady state velocity. The burst amplitude gives the 
concentration of active enzyme. 
 
[P] = A[1-exp(-kobst)] + Vobst      (1) 
 
Single Turnover Assay for Glycosylase Activity.  
Single-turnover glycosylase assays were performed with AAG in excess over the 
0.1 µM DNA substrate. The standard conditions were 23oC, 50 mM NaMES (pH 6.0), 1 
mM EDTA, 1 mM DTT, 10% (v/v) glycerol, 0.1 mg/mL BSA, and the ionic strength was 
adjusted to 200 mM with NaCl. Typical reaction volumes were 20 uL, with 3 uL aliquots 
being removed at the desired time and quenched in NaOH and analyzed as described 
above. To determine the rate constant, time points were taken over the entire reaction 
progress curve and the fraction of product was plotted as a function of reaction time. Data 
analysis was performed using Kaleidagraph. In all cases, the reaction progress curves 
followed a single exponential and were fit by Equation #2, in which A is the fraction of 
substrate converted to product at completion (A ≥ 0.94), kobs is the observed single-
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turnover rate constant, and t is the reaction time. Fits were excellent in all cases (R2 ≥ 
0.97).   
 
F = A[1-exp(-kobst)]       (2) 
 
For extremely fast reactions, with half-lives of less than 20 s, some modifications 
to this protocol were made. Equal volumes (3 µL) of enzyme and substrate were mixed 
by hand, with the reaction occurring in the pipet tip, and subsequently quenched in a tube 
containing 6 µL of 0.3 M NaOH. The concentrations indicated throughout are for the 
final reaction mixture after mixing substrate and product. With the assistance of a 
metronome, time points could be accurately and reproducibly quenched at times as fast as 
4 s.  
 For each substrate, we determined the concentration dependence by varying the 
concentration of AAG under single turnover conditions ([AAG] ≥ [DNA]). The rate 
constants for 4-8 independent reactions were averaged and the standard deviation was 
calculated in Excel. Plots of the observed rate constant as a function of the concentration 
of AAG were fit by a hyperbolic equation analogous to the Michaelis-Menten Equation 
(Eq. #3), in which the maximal observed rate constant (kmax) corresponds to the rate of  
the reaction at a saturating concentration of enzyme and the K1/2 value indicates the 
concentration at which half of the substrate is bound. The ratio of kmax/K1/2 is analogous 
to the steady state rate constant kcat/KM, which is commonly referred to as catalytic 
efficiency. Comparison of kcat/KM values for different substrates takes into account 
differences in both binding and catalysis. 
 
kobs = kmax[AAG]/(K1/2 + [AAG])     (3) 
 
Free Energy Calculations.  
A linear free energy relationship correlating the catalytic efficiency of different 
inosine mismatches with the thermodynamic duplex stability demonstrates an inverse 
relationship between duplex stability and catalytic efficiency. The ∆∆G value for the 
relative catalytic efficiencies were calculated according to the equation, ∆∆G = -RT 
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ln(kcat/KMrel), in which kcat/KMrel is the ratio of the kcat/KM value for the mismatch divided 
by that of the fastest substrate, the single nucleotide bulge (Table 3-3). The ∆∆G values 
for duplex stability were calculated from a comprehensive study of the nearest neighbor 
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Additional data figures and accompanying discussion to support Chapter 3 
 
SUPPORTING RESULTS AND DISCUSSION 
 
Figure B-1 shows the sequence of the oligonucleotide substrates.  A 
representative gel and accompanying time course are shown for the single turnover 
glycosylase assay (Figure B-2). Additional representative exponential fits to reactions 
with rate constants that varied by 4 orders of magnitude (Figure B-3). The concentration 
dependence of the single turnover reaction for mismatch and bulge substrates from Figure 
3-2 in the text have been replotted with more appropriate scales (Figure B-4). The AAG 




Figure B-1. Sequence of oligonucleotides that were used in this study. The inosine-containing 
strands had a 5’-fluorescein attached by a 6-aminohexyl linker (fam). 
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displayed in Figure B-5. The similar behavior for two different oligonucleotides, one of 
which is flanked by poly-thymidine stretches, suggests that the observed reaction took 
place on a single stranded oligonucleotide.  Several previous studies have examined the 
glycosylase activity of AAG towards single strand and mismatched oligonucleotides 
substrates. These supporting references are provided and our results are discussed in the 




Evaluation of data quality. 
Representative time courses are shown for the single turnover glycosylase activity 
of AAG on the slowest substrates, single stranded DNA, and the fastest substrate, the 
single nucleotide bulge (Figure B-2). These plots demonstrate that fast and slow reactions 
all followed the expected single exponential. This indicates that AAG is stable under 
these assay conditions, and that fast time points could be reliably taken by hand. 
Activity of AAG towards mismatches and a single nucleotide bulge.  
The single turnover rate constants for the substrates mentioned in the main text 
and an additional single-stranded substrate are summarized in Table B-2. The best fit of 
the concentration dependence is reported and the error was estimated by fitting the 
concentration dependence of all of the independently determined rate constants (from 
  –TIC– 
–AXG– 
 X=C X=A X=T X=G 
∆G TI/AX -0.46 ± 0.06  0.09 ± 0.06  0.36 ± 0.06  0.76 ± 0.06 
∆G IC/XG -1.07 ± 0.08 -1.33 ± 0.08 -0.54 ± 0.08 -0.74 ± 0.08 
∆G TIC/AXG -1.53 ± 0.14 -1.24 ± 0.14 -0.18 ± 0.14  0.02 ± 0.14 
∆∆G  (0) ± 0.28 0.29 ± 0.28 1.35 ± 0.28 1.55 ± 0.28 
Table B-1. Calculation of relative duplex stabilities for the inosine mismatches. Duplex stabilities 
were calculated using nearest neighbor rules from a systematic study of duplex stability for inosine 
mismatches in different sequence contexts [12]. All values are expressed in units of kcal/mol. The 
difference in free energy (∆∆G is calculated by substracting the value of ∆G for the most stable pair 
(I•C) from the ∆G for the indicated pair and therefore ∆∆G for I•C is defined as zero.  
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~50 individual single turnover reactions) with a hyperbolic equation (Eq. #2) using 
Kaleidagraph.  
The full single turnover characterization of inosine-mismatches has not been 
previously reported for any sequence context, but several previous studies have tested 
whether the opposing base has an effect on the maximal single turnover rate constant. 
These are summarized in Table B-3. The maximal rate constants that we report with a 
fluorescence-based glycosylase assay are within 2-fold of the values reported previously 
using a 32P-based assay [1].  
This suggests that the change in reaction conditions and in labeling method does 
not have a substantial effect on AAG catalysis. The differences between I•T and I•C 
range from 2–5 fold for different sequence contexts and different reaction conditions. 
Other studies have used a fixed concentration of AAG and DNA to report initial rates for 
glycosylase activity towards inosine mismatches [2-4]. These studies found much larger 
effects, with the I•T mismatch being acted upon with 10 to 50-fold faster a rate than the 
I•C mismatch. The similar 24-fold greater catalytic efficiency towards I•T than I•C that 
we have measured for kcat/KM suggests that the previously published results also 
	  
Figure	  B-­‐2.	  	  Representative	  single-­‐turnover	  glycosylase	  assay.	  (A)	  The	  fluorescence	  scan	  of	  a	  
20%	  polyacrylamide	  gel	  shows	  a	  reaction	  time	  course	  with	  1µM	  AAG	  and	  0.1µM	  I	  bulged	  
substrate.	  	  The	  25mer	  substrate	  is	  converted	  into	  a	  12mer	  product	  after	  AAG-­‐catalyzed	  N-­‐
glycosidic	  bond	  cleavage	  and	  alkaline	  cleavage	  of	  the	  abasic	  site.	  A	  control	  reaction	  in	  which	  AAG	  
was	  omitted	  demonstrates	  that	  the	  inosine-­‐containing	  substrate	  is	  stable	  to	  the	  glycosylase	  
assay	  and	  provides	  the	  background	  signal	  expected	  at	  the	  initiation	  of	  the	  reaction.	  (B)	  The	  
quantified	  data	  is	  fit	  to	  a	  single	  exponential	  curve	  (Eq.	  #2)	  and	  gives	  a	  kobs	  value	  of	  5.5	  min-­‐1	  with	  
an	  R2	  value	  of	  0.99.	  Several	  independent	  experiments	  were	  performed	  for	  each	  concentration	  of	  
AAG	  and	  the	  average	  and	  standard	  deviation	  are	  reported	  in	  Figure	  B-­‐3.	  
A B  
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compared kcat/KM. This indicates that AAG has a strong preference towards an I•T 
mismatch, since the competition between substrates for a given enzyme is determined by 
their relative kcat/KM values. 
 
Since we have analyzed the full concentration dependence, these data allows us to 
confirm that most of the difference in kcat/KM is attributed to adifference in binding 
affinity, with comparably small differences in reaction rate once the substrate is bound 
(Table B-2). The origin of this large difference in ground state binding is currently 
unclear. One possible explanation is that the ground state complex is stably flipped (Kflip 
>>1; as has recently been observed for the 1,N6-ethenoadenosine lesion [5]. In this case, 
the more stable base pairs will require additional binding energy to reconfigure the 
substrate and flip out the inosine lesion. However, we cannot rule out the possibility that  
 
 
Opposing Base K1/2 (µM) kmax (min-1) kcat / KM  (M-1s-1)b 
Relative 
kcat/KMc 
None (bulge) 0.080 ± 0.008d 5.4 ± 0.1 68 ± 7 3.2 
T 0.30 ± 0.02 6.3 ± 0.1 21 ± 1.4 (1) 
G 0.41 ± 0.05 1.5 ± 0.1 3.7 ± 0.5 0.18 
C 3.8 ± 0.6 3.3 ± 0.2 0.87 ± 0.15 0.041 
A 2.3 ± 0.5 2.0 ± 0.1 0.87 ± 0.19 0.041 
Single strand sse 0.14 ± 0.06d 0.0027 ± 0.0002 0.019 ± 0.007 0.00092 
Single strand ssTe 0.86 ± 0.09 0.0017 ± 0.0001 0.002 ± 0.0002 0.000095 
	  
Table B-2. Kinetic parameters for single turnover inosine DNA glycosylase activity of AAGa. A 
simplified form of this table is shown in the text (Table 1). aData were collected at 23 oC in 50 mM 
NaMES, pH 6.1, 1 mM EDTA, 1 mM DTT, 0.1 mg/mL BSA and with an ionic strength of 200 mM 
(adjusted with NaCl). bkcat/KM is calculated from the ratio of kmax/K1/2, since this process monitors the 
same steps as kcat/KM in steady state kinetics. cThe relative kcat/KM value was obtained by dividing the 
kcat/KM for a given substrate by the kcat/KM value for the I•T mismatch. dThese values of K1/2 are similar 
to the concentration of substrate (0.1 mM), so they should be considered upper limits to the true K1/2 
value. If the K1/2 value is significantly lower than the kcat/KM would also be higher. eThe two different 
single stranded sequences that were tested are shown in Figure S1. The errors for the kmax and K1/2 
values were estimated from curve fitting using nonlinear least squares regression to fit a hyperbolic 
concentration dependence (Equation S3) to all of the individual values of kobs determined for a given 
substrate (Kaleidagraph), and this error was propagated to determine the error in kcat/KM.  
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the opposing base is directly contacted in an initial recognition complex that differs from 
the specific lesion recognition complex that has been observed crystallographically and 
that shows no specific contacts to the opposing base. Stopped-flow binding of 1,N6- 
ethenoadenosine to AAG provides evidence that such an intermediate exists for this 
substrate [5]. Future studies looking directly at the rate and equilibrium constant for 
flipping of inosine from difference sequence contexts will be required to address this 
issue. 
A previous study concluded that an opposing base is required for AAG 
glycosylase activity, [6] because a lesion that was placed opposite a reduced abasic site 
(tetrahydrofuran) was not a substrate for AAG. However it is not possible to rule out the 
possibility that AAG might bind to the reduced abasic site directly since AAG bind with 
high affinity to this product mimic [6]. The finding that a single nucleotide bulge is an 
excellent substrate for AAG demonstrates that an opposing base is not required. 
Therefore, the decrease in glycosylase activity across from an abasic site is due either to 
A B 	  
	  
Figure B-3. Representative data for single turnover glycosylase activity with the slowest and 
fastest substrates. (A) For the thymidine-rich single-stranded substrate time points were taken over >3 
days and the triplicate reactions are shown with saturating (15 mM) and sub-saturating (0.2 mM) AAG. 
(B) For the single nucleotide bulge times points were taken from 5-150 s. Duplicate reactions at 
saturating (3 mM) and subsaturating (0.1 mM) AAG are shown. For all substrates and all concentrations 
of AAG the reaction progress curves followed single exponentials and went to a similar endpoint of 
≥95% cleaved. 
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inhibition (binding directly to the abasic site) or to an alternative conformation that is less 
efficiently recognized by AAG.  
Activity of AAG towards single-stranded inosine-containing DNA.  
It has previously been reported that AAG has no detectable glycosylase towards 
inosine in single stranded DNA [7]. This is in contrast to oxanine and 1,N6-ethenoA for 
which double stranded DNA is only modestly preferred by AAG [8]. A recent report  
 
concluded that AAG also has robust activity towards inosine in a single strand, [9] but 
these reactions did not appear to go to completion and it was noted that the sequence of 
the oligonucleotide that was used was self-complementary in the region of the inosine 
lesion raising the possibility that the activity observed was not towards a single stranded 
lesion. We find that the single stranded oligonucleotide that we have characterized is an 
extremely poor substrate for AAG, with maximal single turnover rate constant that is 
2000-fold slower than that of the I•T mismatch (Table B-2). Similarly, the catalytic 
efficiency is increased by 1000-fold when the single strand is annealed to its complement 
to form an I•T mismatch. Although the sequence that we initially used is not predicted to 
form stable secondary structure, we were concerned that a high concentration of AAG 
might stabilize an otherwise unstable structure that would allow faster rate of excision. In 
B A 	  
 
Figure B-4. Concentration dependence for the inosine DNA glycosylase activity of AAG 
replotted from Figure 3-2.  The axes are adjusted to facilitate comparison of individual substrates. 
(A) The I·T mismatch ( ) and the I bulge ( ) show very similar single turnover kinetics.  (B) AAG 
shows decreased glycosylase activity towards I·C ( ), I·A ( ), and I·G mismatches ( ) with 
decreases in kmax and increases in K1/2 (See Table S2 for the kinetic values and error estimates for 
the different substrates). 
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this case, these large effects might overestimate the activity of AAG on single-stranded 
inosine. Therefore, we designed a sequence that was all pyrimidines except for the central 
inosine lesion, by replacing the flanking nucleotides with thymidines. The single turnover 
excision data for this alternative sequence is summarized in Figure B-5 and Table B-2. 
The less diverse sequence bound 6-fold weaker and had a maximal rate that was ~1.5-
fold slower than the heterogenous sequence. This corresponds to a 9-fold decrease in the 
catalytic efficiency for the thymidine-rich sequence (Table B-2). It is not clear what the 
origin of this sequence preference is, but it is not simply explained by a difference in 
secondary structure. If some duplex were formed, an increase in the maximal single 
turnover rate constant would be expected. These results indicate that inosine present on 
single-stranded DNA is a very poor substrate for AAG. 
A linear free energy relationship for the inosine DNA glycosylase activity of AAG.  
The barrier to nucleotide flipping can be evaluated by comparing the activity of 
the enzyme towards a lesion that is present in different base pairing contexts. The rate 
constant kcat/KM monitors the differences in energy between the ground state duplex in 
solution and the transition state bound to the enzyme with the lesion flipped out. Since 
	  
	  
Figure	  B-­‐5.	  Single	  turnover	  inosine	  DNA	  glycosylase	  activity	  of	  AAG	  for	  single-­‐stranded	  
substrates.	  The	  data	  for	  the	  heterogenous	  sequence	  (ss,	  ●)	  and	  the	  T-­‐rich	  sequence	  (ssT,	  ■)	  
are	  directly	  compared.	  See	  Figure	  1	  for	  the	  complete	  oligonucleotide	  sequences.	  Each	  point	  
indicates	  the	  average	  of	  3-­‐6	  independent	  determinations	  and	  the	  error	  bars	  indicate	  one	  
standard	  deviation	  from	  the	  mean.	  In	  several	  cases	  the	  error	  bars	  are	  smaller	  than	  the	  
symbols	  that	  were	  used.	  The	  single	  turnover	  rate	  constants	  are	  given	  in	  Table	  B-­‐2.	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the bond being broken is identical in each case, the transition state is the same for each 
mismatch. Therefore, differences in reaction rate between different mismatches will be 
dominated by specific differences between the different base pairs. We have used the 
available data for the contributions of inosine mismatches to the equilibrium constant for 
duplex stability. Duplex stability is expected to be sensitive to how well a given 
mismatch is accommodated in the duplex and therefore serves as a useful surrogate for 
the base pairing stability of a given mismatch. The relative duplex stability for the 
sequence context that we used were calculated as described in the Materials and Methods 
and outlined in Table B-1. The relative kcat/KM values for AAG-catalyzed glycosylase 
activity were also converted into changes in free energy (∆∆G) and plotted in the text 
(Figure 3-3). Since only the natural inosine mismatches were used this is a very limited 
data set. It will be necessary to look at a larger set of natural and unnatural base pairs in 
order to obtain sufficient confidence in the exact slope. Nevertheless, the observed slope 
is sufficiently steep that we believe that the general trend is informative. 
The best linear fit gives a slope of -0.96 (R2=0.67). This strong negative 
correlation indicates that the differences in duplex stability for the different mismatches 
are fully experienced in going from that ground state to an extrahelical AAG-bound 
transition state. This supports the notion that AAG does not make specific contacts with 
the opposing base [10, 11]. However, this conclusion is tenuous because there is a large 
	  
  Normalized kmax 
Sequence Reference I•T I•G I•C I•A 
–TIC– This study (1) 0.24 0.52 0.32 
–TIC– [1] (1) 0.14 0.40 0.18 
–GIG– [4] (1) 0.31 0.31 0.11 
–TIG– [6] (1) ND 0.19 ND 
	  
Table B-3. Comparison of kmax values for the glycosylase activity of AAG towards inosine in 
different mismatches. The saturating single turnover rate constant, kmax, was normalized by dividing 
the value for a given mismatch by that of the most active mismatch context I•T. ND, not determined.	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deviation between the two least stable mismatches (I•T and I•G). If I•G deviates due to a 
negative effect, then the slope would be considerably steeper. If I•T deviates due to a 
positive effect, then the slope is less steep (b = -0.6; R2 = 0.97). Since the biological 
function of AAG is to recognize and repair I•T mismatches, the natural context for 
deamination of an adenosine in DNA, it seems plausible that there may be factors beyond 
duplex destabilization that would lead to more efficient recognition by AAG. Previously 
it has been suggested that the unique wobble base pair geometry that is formed by an I•T 
pair could be responsible for the more efficient recognition by AAG [6]. 
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HUMAN ENDONUCLEASE III (NTH1) INITIATES DELETION OF A BULGED, 
DAMAGED BASE 
 
Small insertions and deletions (indels) are common mutations that have a high 
probability of causing a loss of gene function (1). Indels that change the coding region of 
a gene by integers other than 3 bp are known as frameshift mutations, because they 
disrupt the normal reading frame and alter the amino acid sequence. The most common 
indels involve loss or gain of a single nucleotide, but larger indels occur particularly in 
repetitive regions of the genome. Frameshift mutations predominantly arise from DNA 
replication errors in which the primer/template pair slips in a polymerase active site and 
escapes exonucleolytic proofreading to produce a bulged (unpaired) region (2). Several 
factors are known to increase the frequency of polymerase slippage, including damaged 
nucleotides, abasic sites, and DNA intercalators (3). Failure to repair a bulged 
intermediate prior to a subsequent round of DNA replication will produce a single 
nucleotide deletion or insertion. Most bulged intermediates are recognized and repaired 
by the mismatch DNA repair pathway (MMR) (4). Defects in the MMR pathway caused 
by mutations in MMR genes or changes in promoter methylation state that lead to 
decreased expression are commonly observed in hereditary colon cancer (5-7). Increased 
rates of insertions and deletions, particularly in repetitive regions of the genome, are 
considered to be a clinical indicator of defective MMR (8).  
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Intriguingly, increased rates of frameshift mutations have been reported in the 
absence of MMR dysfunction (9, 10). Upregulation of enzymes in the base excision DNA 
repair (BER) pathway has been shown to increase the frequency of frameshift mutations 
(11-13). The BER pathway is responsible for repairing the majority of base lesions that 
occur in the genome due to oxidative or alkylative damage (14, 15). A DNA repair 
glycosylase initiates the BER pathway by recognizing a damaged nucleotide and 
catalyzing the hydrolysis of the N-glycosidic bond to liberate the damaged nucleobase 
(16, 17). Human alkyladenine DNA glycosylase (AAG) has been reported to affect 
frameshift mutations via two distinct mechanisms. The first mechanism involves the high 
affinity binding of AAG to a bulged nucleotide which blocks access by the MMR 
pathway, resulting in increased levels of both insertions and deletions. (18). A second 
mechanism relies on the ability of AAG to catalyze the excision of a bulged lesion (19) 
and initiate the BER pathway to delete the bulged nucleotide. BER deletion of a bulged 
nucleotide leads to an immediate -1 frameshift, but prevents +1 frameshift events. This 
activity would produce a unique spectrum of frameshift mutations, resulting in a bias for 
-1 frameshift mutations (20). This mechanism may contribute to the known 3-6 fold bias 
for -1 frameshifts in the human genome (21-23). 
In addition to AAG, two other human glycosylases have been shown to have the 
ability to excise a bulged lesion. The bifunctional glycosylase/lyase Nei-like protein 1 
(Neil1) excises oxidized guanine lesions in a bulged confirmation (24) and uracil DNA 
glyosylase excises bulged uracil lesions (20). These glycosylases represent three of the 
four structural families of human glycosylases (25). This suggests that it is common for 
glycosylases to recognize bulged lesions, and that for many forms of DNA damage there 
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could be a competition between the MMR pathway that detects helix discontinuities and 
glycosylases that detect distinct modified bases. In the current work we examined a 
member of the largest superfamily of human DNA glycosylases, the helix-hairpin-helix 
superfamily (26). We investigated the ability of the human homolog of endonuclease III 
(Nth1) to excise a bulged lesion and initiate production of single nucleotide deletion by 
BER.  
Nth1 is a bifunctional glycosylase/lyase that recognizes a wide range of 
oxidatively damaged pyrimidines, including 5,6-dihydrouracil (DHU) that is formed by 
oxidative damage of cytosine (27). There are crystal structures of prokaryotic homologs 
of Nth1 (28-30) and there have been numerous biochemical studies examining the 
activity of Nth1 toward damaged pyrimidines (27, 31, 32). Nth1 is not essential in mice 
and can be deleted, presumably because other DNA repair glycosylases serve as backup 
activities (33). Indeed, when both Nth1 and Neil1 are deleted in mice this results in a high 
incidence of tumors (34).  
We compared the rates of Nth1-catalyzed excision of a DHU•G mismatch and 
single nucleotide bulge and found that Nth1 discriminates against a bulged lesion by a 
factor of ~20-fold. Nevertheless, Nth1 rapidly excises a DHU lesion from a single 
nucleotide bulge to initiate deletion of the bulged nucleotide via BER. In human nuclear 
extracts the rate of deletion of a DHU bulge is comparable to the rate of repair of a 
DHU•G mismatch. There is now evidence that  glycosylases of every known structural 
family have robust catalytic activity toward bulged, damaged bases, suggesting that it is 
difficult for base flipping enzymes to rigorously exclude bulged lesions. As bulged 
lesions can occur during replication of damaged templates or as a result of spontaneous 
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damaged of an unpaired nucleotide, there is considerable potential for the BER pathway 
to compete with the MMR pathway for recognition of nascent indels.  
MATERIALS AND METHODS 
Recombinant Protein 
 Full-length APE1 (35) and DNA polymerase β were expressed in Escherichia coli 
and purified as previously described (36). Purification of the catalytic domain of DNA 
ligase I (Δ232), lacking the first 232 amino acids, has been previously described (37). 
The concentration of APE1, polymerase β, and DNA ligase I were estimated from their 
UV absorbance using the calculated extinction coefficients at 280 nm. Full-length Nth1 
was cloned as an N-terminal 6XHis-sumo fusion and the sequence verified by 
sequencing. Recombinant protein was produced in Rosetta 2 E. coli using autoinduction 
and cells were lysed in 25 mM potassium phosphate pH 7.4, 10% glycerol, 300 mM NaCl 
using a cocktail of protease inhibitors (Roche). After purification using NTA-Ni2+ 
agarose and elution with an imidazole gradient, the sumo tag was removed with ULP1, 
and Nth1 was further purified with cation exchange chromatography using SP sepharose. 
Peak fractions were pooled and exchanged into storage buffer (50 mM NaHEPES, pH 
7.5, 100 mM NaCl, 10% glycerol, 5 mM b-mercaptoethanol) and frozen at -80 oC. The 
concentration of Nth1 was determined by active site titration (Figure C-2). Stability of 
Nth1 at 4oC was limited, with approximately 8% loss of activity per day (Figure C-3). 
Therefore, fresh aliquots of Nth1 were thawed from frozen stocks (-80 oC) immediately 





 DNA oligonucleotides were synthesized by commercial sources and purified by 
denaturing polyacrylamide gel electrophoresis (PAGE; 6.6M urea and 1x TBE) as 
described (19). Phosphorothioate containing oligonucleotides were purified in the 
presence of 0.1mM dithiothreitol (DTT). The sequences of the oligonucleotides are 
illustrated in Figure C-1. 5’-fluorescein (6-fam) labeled oligonucleotides harbor a 
centrally located 5,6-dihydrouracil lesion or cytosine nucleotide (Figure C-1). 
Complementary strands are unlabeled. The labeled oligonucleotide was annealed with a 
24-mer complement to create a single nucleotide bulge, or with a 25-mer complement to 
create a central base pair (X·Y). The 25-mer sequence was extended to a 35-mer to 
improve stability of nicked BER intermediates at 37°C. Additionally, the ends are 
decorated with C3-spacer aliphatic chains, bridged by a phosphorothioate linkage to 
prevent non-specific exonuclease degradation in cell extract. Oligonucleotides were 
annealed by heating to 37 °C for 5 min and then transferring to an ice bath. 
General glycosylase assay 
(6-fam)-labeled oligonucleotides (25mer) were incubated with Nth1 at 23°C in 
glycosylase buffer containing 50mM NaHEPES (pH 7.5), 1mM DTT, 1mM EDTA, 0.1 
mg/ml BSA, 10% glycerol and additional NaCl to reach desired ionic strength. Samples 
were quenched with two volumes of 0.3M NaOH to reach a final concentration of 0.2M. 
Abasic sites were quantitatively converted to DNA breaks by heating at 70°C for 10 min, 
followed by the addition of 3.3 volumes formamide/EDTA containing 0.05% w/v of both 
bromophenol blue and xylene cylanol as tracking dyes. DNA breaks were separated by 
denaturing PAGE and imaged with a Typhoon trio (GE Healthcare) using 488 nm 
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excitation and a 520BP40 emission filter. Fluorescence intensity of individual bands was 
determined with Image-Quant TL (GE Healthcare). The fraction of glycosylase product 
was determined by dividing the fluorescence intensity of the 12-mer product band by the 
sum of the 12-mer product and 25-mer substrate bands. The fraction was converted into 
concentration by multiplying by the total amount of DNA substrate present as previously 
described (19). 
Single turnover glycosylase assay 
Single turnover glycosylase assays were performed with Nth1 in at least a 2-fold 
excess over the DNA substrate. In most cases, 100nM DNA substrate was present, but 
20nM DNA was used when Nth1 concentration was 40nM and 80nM. Single turnover 
rates were measured at 23°C in the glycosylase buffer described above. Single turnover 
reactions proceed extremely fast, most with half-life of less than 20 s. This required a 
technique in which equal volumes (3μl) of enzyme and substrate were mixed by hand, 
with the reaction occurring in the pipette tip. 3μl timepoints were quenched into a tube 
containing 6μl 0.3mM NaOH as described (19). Timepoints could be taken accurately 
and reproducibly as fast as 3 s with the aid of a metronome. In all cases, reaction progress 
curves were fit by a single exponential (eq 1), where A is the fraction of substrate 
converted to product at completion (A>0.90). kobs is the observed single turnover rate 
constant and t is the reaction time. K1/2 was too low to measure for all substrates expect 
the DHU-bulge (Figure 4-1). For the DHU-bulge the individual values of K1/2 and kmax 
were determined by varying enzyme concentration under single turnover conditions and 
fitting with a hyperbolic dependence (eq 2). The saturating single turnover rate constant 
	  87	  
(kmax) was determined at 3μM and 6μM Nth1 concentrations using 0.1μM DHU substrate. 
Reaction rates were independent of Nth1 concentration in all cases.  
 F = A[1-exp(-kobst)]       (1) 
 kobs = kmax[Nth1]/(K1/2+[AAG])     (2) 
Steady state glycosylase assay 
Multiple turnover of Nth1 was measured under glycosylase conditions described 
above. A linear fit of the initial rate was determined from timepoints less than 20% 
product formation. Relative specificity for DHU substrates was determined by directly 
competing two oligonucleotides. Initial velocities of each substrate are proportional to the 
relative kcat/Km values as described by eq 3 (35). Typically, a 20μl reaction contained 
100nM of each (6-fam)-labeled substrate was incubated with 2nM Nth1. 3μl timepoints 
were quenched in 6μl 0.3M NaOH and analyzed as above.  
VA/VB  = (kcat/Km)A[A]/(kcat/Km)B[B]     (3) 
In vitro BER reconstitution 
 Recombinant human proteins were used to reconstitute BER activity on a DHU-
bulge. Reactions were incubated at 23°C under BER conditions of 50 mM NaHEPES (pH 
7.5), 100 mM NaCl, 5 mM MgCl2, 4 mM ATP, and 2.5 μM of each dNTP. Reactions 
contained 200 nM DHU-bulge (25mer) substrate with 50 nM Nth1, 120nM APE1, 5nM 
polymerase β, and 20nM ligase I, in a total volume of 20 μL. 3 μL timepoints were 
quenched directly into an equal volume of formamide/EDTA loading buffer. Samples 
were heated for 5 min at 70°C and anaylyzed by denaturing PAGE as above. Abasic sites 
remained intact during this procedure. Using the same protocol, intermediates in the BER 
processing of a DHU-bulge are observable by omitting each enzyme in succession. 
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Reactions were quenched after 60 min in an equal volume of formamide/EDTA loading 
buffer and analyzed as above. 
Reaction of a uracil containing U-bulge (25mer) with E. Coli UDG (New England 
Biolabs) produces a bulged abasic site. Addition of Nth1 with UDG processed the U-
bulge to a nicked intermediate, 3’-dR. BER reconstitution reactions with 3’-dR 
substituted 1mM TCEP in the place of DTT to prevent modification of the 3’-unsaturated 
sugar (Figure C-9). 
Glycosylase assay in HeLa nuclear extract 
 Glycosylase reactions in HeLa NE were monitored at 37°C in a buffer containing 
50 mM NaHEPES (pH 7.5), 100 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.1 mg/ml of 
bovine serum albumin, and 10% (v/v) glycerol. Typically, 20μl reaction volume 
contained 10nM 5’-(6-fam)-labeled substrate and 0.4 mg/ml HeLa NE (Santa Cruz 
Biotechnology). 3μl aliquots were removed at the desired timepoints and quenched with 
2 volumes of 0.3M NaOH and analyzed as above.  
BER assays in HeLa nuclear extract 
 Assays for the processing of labeled oligonucleotides in cellular extract were 
performed at 37°C in 50 mM NaHEPES (pH 7.5), 100mM NaCl, 5mM MgCl2, 4mM 
ATP, and 25μM of each dNTP as described previously (20). Typically, 10nM (6-fam)-
labeled substrate and 100nM unlabeled DNA were incubated with 0.4 mg/ml of HeLa NE 
in a reaction volume of 20μl. Samples were taken by quenching 3μl aliquots into an equal 
volume of formamide as above. The amount of repair that had occurred was determined 
by quenching reactions at indicated time with EDTA (10 mM final). A vast excess of 
recombinant Nth1 (2μM) was added along with 10nM DHU·G (25mer) as an internal 
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standard for Nth1 glycosylase activity. After 30 min incubation at 37 °C, these reactions 




In order to characterize the kinetics for Nth1-catalyzed glycosylase activity it is 
important to know the concentration of active enzyme. As most glycosylases dissociate 
slowly from their products, it is common to observe burst kinetics in which the transient 
burst corresponds to the concentration of the active enzyme. Therefore we used burst 
kinetics to determine the active concentration of Nth1 and this is the concentration that is 
referred to in all subsequent experiments (Figure C-2).  
In the current study we focused on 5,6-dihydrouracil (DHU) as a representative 
substrate of Nth1 (27). DHU is a ring-saturated pyrimidine lesion formed by a radical 
reduction and deamination of cytosine (38). We found that DHU is susceptible to non-
enzymatic degradation under conditions normally used to anneal DNA and to analyze 
DNA glycosylase kinetics (see Appendix C; Figures C5-7). However, by annealing at 
neutral pH and lower temperature we were able to prevent these undesirable side 
reactions and obtain well-behaved enzymatic kinetics. It is a concern that other studies of 
DHU may have been affected by its intrinsic reactivity. The spontaneous ring-opening 
and breakdown of dihydrouridine ribonucleotide has been characterized and a similar 











Figure 4-1. Nth1 glycosylase activity under single turnover conditions. (A) Nth1 glycosylase 
activity was measured using a fluorescently labeled oligonucleotide with a centrally located DHU-
bulge. Products of Nth1 catalysis were cleaved under alkaline conditions and samples were analyzed by 
denaturing PAGE. (B) Representative data for single turnover glycosylase activity with a DHU-bulge at 
23°C in 200mM [Na+], pH 7.5. Each data point corresponds to the average and standard deviation of 2-
4 individual reactions. (C) Concentration dependence for Nth1 catalysis of a DHU-bulge at 23°C under 
increasing [Na+]. Lines represent the best fits to a hyperbolic concentration dependence: kobs = 





Single turnover excision of 5,6-dihydrouracil in different structural contexts 
We used single turnover assays, with Nth1 in excess over DNA, to evaluate the 
ability of Nth1 to recognize and excise a bulged DHU lesion. The single turnover 
reaction reports on all of the steps up to and including the first irreversible step, and 
therefore is not affected by slow product dissociation. We found that NaOH (0.2 M final 
concentration) rapidly quenches Nth1 activity. Subsequent alkaline hydrolysis converts 
both abasic sites and β-elimination products into a 5’phosphate that provides a 
quantitative measure of Nth1 glycosylase activity (Figure 4-1A). We observed very rapid 
excision of DHU from a bulge, and the reactions are complete in under a minute at 
saturating concentration of Nth1, demonstrating robust activity toward a single nucleotide 
bulge (Figure 4-1B). The reaction progress curves follow a single exponential (Figure 4-
1B), and the plot of the observed single turnover rate as a function of Nth1 follows a 
hyperbolic dependence on protein concentration (Figure 4-1C). The saturating single 
turnover rate constant (kmax) reaches a value of ~20 min-1.  
As most DNA binding enzymes are strongly dependent upon monovalent cation 
concentration, we repeated the single turnover excision experiments at a range of Na+ 
concentrations from 150-300 mM and the results are summarized in Figure 4-1C. As the 
concentration of Na+ is increased it takes significantly higher concentration of Nth1 to 
saturate.  
 To compare the catalytic activity of Nth1 on a bulge lesion to a canonical DHU·G 
mismatch, we also performed single turnover kinetic analysis of this mismatch. In 
contrast to the bulge, the mismatch is saturated at low nM concentration of Nth1 (Figure 
4-2A). Under these conditions of 200 mM NaCl, the K1/2 for the DHU•G mismatch is too 
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low to accurately measure and we can only place a limit of ≤20 nM. Nevertheless, the 
maximal single turnover rate (kmax) is identical for both the mismatch and bulge 
substrates. We tested the ability of Nth1 to excise DHU from mismatches with the other 
natural opposing bases and also evaluated to what extent Nth1 can excise DHU from 
single-stranded DNA. The kmax values were determined at saturating concentration of 
Nth1 and are summarized in Figure 4-2B and Table 4-1. Once saturated, Nth1 shows 
essentially identical single turnover glycosylase activity toward all duplex contexts that 
were tested. In contrast, the rate of DHU excision in single strand DNA is decreased by 
several orders of magnitude (Figure 4-2B). Inefficient excision of a single stranded lesion 
has been observed for several glycosylases, including AAG (19).  
Multiple turnover kinetics to determine the catalytic efficiency of Nth1 toward DHU 
in different contexts 
To better quantify the specificity of Nth1 we also performed multiple turnover 
kinetics. We measured the initial rates for excision of DHU from the DHU-bulge at a 
range of DNA concentrations and the hyperbolic substrate concentration dependence is 
shown in Figure 4-3A. This gives a kcat value of 0.24 min-1, two-orders of magnitude 
slower than the single turnover rate constant, and a KM value of 82 nM that is somewhat 
smaller than the K1/2 value of 520 nM. This shows that a step associated with product 
dissociation limits the multiple turnover excision of DHU from a bulge. The kcat/KM value 
is 6.8x104 M-1s-1 and this reports on substrate binding and all of the steps up to and 
including the first irreversible step, presumably N-glycosidic bond cleavage. The tight 
binding of Nth1 to the DHU•G mismatch precluded measuring the kcat/KM value directly 











Figure 4-2. Single turnover excision of DHU by Nth1. 
(A) Comparison of hyperbolic concentration dependence of DHU-bulge and DHU·G structural contexts 
at 25°C in 200mM [Na+]. The K1/2 value of DHU·G is at least 12-fold lower than DHU-bulge. (B) 
Values of kmax were measured at saturating Nth1 concentration. Values are average kobs for two 
independent reactions at 3μM and 6μM [Nth1]. Error bars represent the standard deviation of kobs. kmax 






Therefore, we used direct competition experiments to measure the relative kcat/KM values 
for the different opposing base context. 
Competition between two substrates binding to a single active site is given by the relative 
concentrations of the two substrates and their respective kcat/KM values (Figure 4-3B; Eq 
3). For competition experiments, we extended the lesion-containing strand by 6 T at the 
5’end so that the substrate and product would differ by 6 nt from our reference 25mer 
substrate and they could be readily resolved by denaturing PAGE (see Appendix C; 
Figures C-1 and C-8). Competition between the blunt end 25mer and the 5’-extended 
oligonucleotide, both with a central DHU•G mismatch, established that the 5’ poly T 
extension does not affect Nth1 specificity (Figure C-8). As an example of this approach, 
equal concentrations of a DHU•G and DHU•A mismatch were combined and the initial 
rates of Nth1-catalyzed excision were measured (Figure 4-3C). These data demonstrate 
that Nth1 has almost a 10-fold preference for the DHU•G context over the DHU•A 
context under conditions of 200 mM NaCl. Analogous experiments were used to 
determine the relative kcat/KM values for all of the different contexts (Figure C-7) and the 
results are summarized in Table 4-1. It was predicted that DHU•G would be the preferred 
substrate of Nth1, because DHU is expected to arise from oxidation of C. Surprisingly, 
Nth1 shows similar efficiencies of excision of DHU opposite G, T, and C (Table 4-1). 
There is ~20-fold discrimination against DHU•A, ~40-fold discrimination against the 






	  	  	  	  





Figure 4-3. Steady-state excision of DHU by Nth1. (A) Steady-state excision of a DHU-bulge by 2nM 
Nth1 at 200mM [Na+]. Initial rates were calculated from the first 20% of the reaction. Line indicates 
best fit to a hyperbolic concentration dependence. (B) Velocity for two substrates binding to a single 
active site is proportional to the kcat/Km for each substrate. The DNA substrates are abbreviated S and 
the product of Nth1 catalysis is labeled P. (C) Representative plot of the steady-state excision of 
DHU·G and DHU·A(T6). A mixture of 100nM of each DNA substrate was incubated with 2nM Nth1. 







The salt dependence of the single turnover reaction suggested that Nth1 affinity 
for DNA is strongly sensitive to the salt concentration. Under conditions of very tight 
DNA binding the competition experiment does not accurately report on the specificity of 
the enzyme. This is because kcat/KM can become equal to the rate constant for substrate 
binding if every binding event produces product. To evaluate whether 200 mM NaCl 
captures the maximal specificity of Nth1, the DHU•G and DHU•A mismatches were 
competed at sodium concentrations between 100 and 300 mM (Figure 4-3D). These 
results suggest that the binding of the DHU•G lesion may not be fully reversible at 200 
mM. The catalytic specificity of Nth1 that are reported at 200 mM NaCl underestimates 










opposing base kmax (s-1) relative kcat/Kma kcat/Km (M-1 s-1)c 
bulge (none) 23.0 0.026 6.8x104 
G 22.0 0.61 7.7x106 
A 19.0 0.064 1.7x105 
T 20.0 0.73 1.9x106 
C 19.0 (1) 2.6x106 
single strand 0.02 0.0012b 3.1x103 
 
Table 4-1. aRelative kcat/Km values were determined by competition at 200mM [Na+]. 
bLimit for value as measurement did not eliminate any minor contribution of duplex formed 
by annealed to excess unlabeled complement oligonucleotide. ckcat/Km was calculated 
using the experimentally defined kcat/Km for the DHU-bulge of 6.8x104 M-1s-1.  
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Deletion of a DHU-bulge by BER 
We next reconstituted the BER pathway for the complete processing of a DHU 
bulge. The β−elimination reaction that Nth1 catalyzes is distinct from the monofunctional 
glycosylase reaction catalyzed by AAG and UDG (19) and from the β,δ-elimination 
reaction catalyzed by Neil1 (24). The pathways for short-patch BER initiated by Nth1 is 
illustrated in Figure 4-4A. By analogy, two possible pathways can be drawn for deletion 
of a single nucleotide bulge (Figure 4-4B). The main difference is that there is no 
requirement for new DNA synthesis, and therefore it is possible to complete the pathway 
without a requirement for DNA polymerase β (Figure 4-4B; right branch). 
As predicted, the incubation of DHU bulge with BER enzymes Nth1, APE1, 
polymerase β, DNA ligase I and the required substrates and cofactors resulted in robust 
single nucleotide deletion (Figure 4-5). Under these conditions the buildup and 
breakdown of nicked intermediate is observed. To evaluate the proposed pathway (Figure 
4-4B), additional experiments were performed in which individual enzymes were omitted 
from the reaction mixture (Figure 5-6). No reaction occurs in the absence of Nth1 (lane 
3). Omission of APE1 (lane 4) results in formation of the 3’ unsaturated sugar, that we 
attribute to the product of the Nth1 lyase reaction. When polymerase b was omitted (lane 
5), a single nucleotide deletion product (24mer) was observed, in addition to a nicked 
intermediate (12mer 3’-OH). As predicted by the model illustrated in Figure 4-4B, two 
pathways exist for processing of the bulged abasic site resulting from Nth1 glycosylase 












Figure 4-4. Short patch and single nucleotide deletion catalyzed by BER enzymes. 
A pathway for short-patch BER is shown on the left and the proposed pathway for single nucleotide 
deletion is shown on the right. Filled circle represents a damaged nucleotide and an open circle, an 
undamaged nucleotide. Note that only the glycosylase and endonuclease steps differ for the two 
pathways. After APE1 cleavage of the 5’-dRP intermediate is chemically identical to the intermediate 
generated after nacent nucleotide incorporation in the short-patch BER pathway. Nth1 glycosylase 
activity produces a bulged abasic site. Endonucleolytic cleavage of the abasic site by APE1 results in a 
5’-dRP nick with a 3’-OH. Alternatively, Nth1 lyase activity produces a 3’-unsaturated sugar (3’-dR). 
Bifunctional activity by Nth1 is non-obligatory, but both pathways of abasic site processing support 
single nucleotide deletion.  
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bifunctional Nth1-catalyzed β-elimination at the abasic site, followed by APE1 
phosphodiesterase activity, and then DNA ligation. If APE1 acts as an AP endonuclease, 
outcompeting Nth1 at the abasic site, the 5’ termini will be blocked by the dRP group in 
the absence of polymerase b and prevent ligation. Under the conditions tested here, APE1 
outcompetes Nth1 for processing of the abasic site, producing and  explains the persistent 
12mer labeled product. Finally, the omission of DNA ligase (lane 6) resulted in formation 
of the 3’hydroxyl product of APE1. 
We confirmed that APE1 is responsible for the 3’ end processing by preparing a 
nick with a 3’unsaturated sugar and incubating it with different combinations of 
recombinant proteins (Figure 4-7A). The 3’ phosphodiesterase activity of APE1 can be 
observed in lane 3 by the formation of the 3’ hydroxyl, the identity of which is confirmed 
by its ability to be ligated by DNA ligase I (lane 6). DNA polymerase β has no detectable 
AP-lyase activity on this substrate (lane 4). Similar experiments were performed with a 
prepared abasic bulge (Figure 4-7B). Addition of APE1 produces a nicked intermediate 
(12mer 3’-OH; lane 4) that is distinct from the Nth1 product of abasic site processing 
(12mer 3’-dR; lane 6). Polymerase β is necessary for production of the single nucleotide 
deletion product (lane 3), because only the nicked DNA is observed in the absence of 









Figure 4-5. In vitro reconstitution of the single nucleotide deletion pathway with recombinant 
BER proteins. (A) Multiple turnover reconstituted BER reactions at 25°C contained 200nM DHU-
bulge DNA, 50nM Nth1, 120nM APE1, 5nM Polymerase β, and 20nM DNA ligase I. Mg2+ and 
nucleotide cofactors necessary for BER activity were included (see Methods). Timepoints were 
quenched at the indicated time with formamide/EDTA loading buffer and analyzed by denaturing 
PAGE. The transient appearance of nicked intermediate (12mer) precedes the formation of single 
nucleotide deletion (24mer). (B) Quantification of the formation of the 24-mer deletion product and the 
formation and breakdown of the 12-mer nicked DNA intermediate. Data points represent the average 
and standard deviation of three independent experiments. 
	  



















Figure 4-6. In vitro reconstitution of the single nucleotide deletion pathway with 
recombinant BER proteins. Recombinant Nth1, APE1, polymerase β, and DNA ligase I were 
sufficient for the single nucleotide deletion in vitro (lane 2). Omission of any single protein 
gave the expected product (lanes 3-6). Absence of polymerase β (lane 6) shows that APE1 is 
responsible for the majority of abasic site processing. The nicked 12mer (3’-OH) is resistant to 
ligation to due a 5’-dRP. Nth1 AP-lyase activity results in a polymerase β independent 













































Figure 4-7. Processing of Nth1 products by BER  (A) 120nM APE1 was incubated with 
200nM nicked DNA at 23°C. APE1 possesses phosphodiesterase activity and catalyzes the 
removal of the 3’-unsaturated sugar (lane 3). APE1 activity allows formation of deletion 
product (24mer) independently of polymerase β (lane 6 and 7). (B) AP-bulge intermediate is 
processed to single nucleotide deletion (lane 3), but requires polymerase β (lane 5). 


























































Glycosylase excision of a DHU lesion in HeLa nuclear extract 
The reconstitution reaction with recombinant proteins establishes that the 
proposed pathways for deletion of bulged, damaged nucleotide can occur. However, it is 
possible that other proteins might compete with Nth1 for a DHU bulge or some 
downstream intermediate and result in an outcome other than single nucleotide deletion. 
Therefore we examined the reactivity of a DHU bulge in human cell extracts. Although 
we were previously able to observe single nucleotide events with bulged, deaminated 
lesions in human cell extracts (19), the nonspecific nuclease activities that are present 
limits the incubation time. Therefore, we sought to prevent degradation by modifying the 
ends of the oligonucleotide substrates. Similar strategies have been successful in 
preventing nucleolytic degradation (40). We used phosphorothioate linkages to link 
propyl alcohol to the ends (Figure C-1). Control experiments demonstrated that the 
degradation of the protected oligonucleotide duplex was undetectable under our reaction 
conditions (Figure C-10).  
We first examined the ability of HeLa nuclear extract to catalyze excision of 
DHU in a G mismatch and single nucleotide bulge context. As DNA glycosylases do not 
require Mg2+ for activity, and it is an essential cofactor for APE1, DNA polymerases, and 
ligases, we omitted Mg2+ and added 1 mM EDTA. Both the DHU•G and DHU-bulge 
were excised on the minute to hour time scale (Figure 4-8). The rate of excision of the 










	  	  	  	  	  	  	   	  
	  
	  
Figure 4-8. Glycosylase activity in HeLa NE. (A) Bifunctional glycosylase activity was observed in 
HeLa NE as formation of nicked DNA intermediates. A 35mer oligonucleotide (10nM) containing a 
DHU-bulge was incubated in 0.4 mg/mL HeLa NE at 37°C in absence of Mg2+. Formation of a nicked 
intermediate requires elimination of the resultant abasic site (17mer). Timepoints were quenched with 
formamide/EDTA, which preserves abasic sites as 35mer. Bifunctional glycosylase activity is expected 
to produce a 3’-dR nicked DNA. (B) Quantification of nicked product. For lanes 1-6, the two products 
(3’-dR and 3’-OH) were not differentiated. Data points represent the average and standard deviation of 
three independent experiments. 
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Figure 4-9. Base excision repair assays in HeLa NE demonstrates single nucleotide deletion. 
Nuclease resistant 35mer oligonucleotide was incubated in 0.4 mg/ml of HeLa NE at 37°C. 5mM 
MgCl2, 2.4mM ATP, and 25μM of each dNTP were added to support BER activity. Complete 
processing of a DHU-bulge (35mer) to a deletion product (34mer) occurred within 4 hours at 37°C 
(lanes 6-10). The DHU·G mismatch was processed on the same timescale (lanes 1-5), as evidenced by 
the build-up of BER intermediates (17mer). No BER intermediates or products were observed when an 
undamaged cytosine was substituted in place of the DHU lesion, in either a basepaired or a bulge 
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Deletion of a DHU-bulge in HeLa nuclear extract 
Mg2+ and other cofactors were added to reactions in HeLa nuclear extract to allow 
for full BER activity. These conditions supported the production of a single nucleotide 
deletion (34mer) from a DHU-bulge substrate (Figure 4-9). No 24mer was detected with 
a DHU•G mismatch, because BER results in removal of the DHU, incorporation of a C, 
and ligation. No detectable reactions were observed on a Watson-Crick duplex (C•G) or 
on an undamaged C-bulge. In contrast, both the DHU•G substrate and the DHU•G bulge 
were processed to give a nicked DNA intermediate (17mer) and some aphidicolin-
sensitive products that are likely to be the result of long-patch BER (19).  
To confirm that the DHU lesion was removed during the processing reactions in 
the cell extracts, we performed coupled assays similar to those that we reported 
previously (19). The design of the experiment is illustrated in Figure 4-10A. After 
incubation from 0-4 hours in HeLa nuclear extract, reactions were quenched by the 
addition of EDTA to prevent ligation and polymerization, and recombinant Nth1 was 
added in large excess over the substrate DNA. As an internal standard, a 25mer DHU·G 
containing oligonucleotide was added at the same time. During this second 20 min 
incubation any remaining DHU lesion is excised by recombinant Nth1. Reactions were 
quenched in NaOH and all abasic sites and 3’dR groups were hydrolyzed. Complete 
processing of the control 25mer confirms that this protocol completely processes any 
DHU that was present (Figure 4-10B). For the DHU•G substrate, an increasing 
proportion of the 35mer becomes impervious to Nth1 excision and alkaline cleavage 




elapsed time. Similarly, for the DHU-bulge it is the 34mer deletion product that 
accumulates over time. The results of this coupled assay were quantified and summarized 
in Figure 4-10C. Under the BER-permissive conditions both the DHU•G mismatch and 









Figure 4-10. Removal of DHU lesion in HeLa NE. (A) 35mer DNA (10nM) was incubated in HeLa 
NE. At the timepoints indicated, BER processing was quenched with 10mM EDTA. Recombinant Nth1 
(100nM) was added along with a DHU·G containing 25mer as an internal control for Nth1 competency. 
Reaction proceeded for 20min at 37°C before quenching with formamide/EDTA. (B) Removal of DHU 
lesion from 35mer DNA by BER activity in HeLa NE is apparent as resistance to recombinant Nth1 



















Several DNA glycosylases have been found to recognize lesions present in a 
single nucleotide bulge and this activity can result in deletion of the damaged nucleotide 
via mechanisms that are closely analogous to BER pathways for the repair of damaged 
nucleotides present in mismatches (19, 24). It is suggested that these reactions will 
compete against other DNA repair pathways, including MMR and that the collective 
activities of glycosylases will generate a bias for deletions over insertions. To evaluate 
the scope of the competition that is possible, we have examined Nth1, a representative 
member of the largest superfamily of DNA glycosylases, the helix-hairpin-helix 
superfamily. In this study, we used kinetic experiments to determine the efficiency of 
Nth1 to excise a DHU lesion in several structural contexts, including a single nucleotide 
bulge. Our results show that Nth1 discriminates strongly against a single nucleotide bulge 
at the initial binding step, but lacks the ability to discriminate once it is bound. 
Apparently lesion recognition does not limit the overall reactions for processing of 
bulged or mismatched DHU lesions, because they are processed with similar rates in cell 
extracts and reconstituted reactions. This study extends the repertoire of enzymes (and 
types of damage) that can impact the frequency of frameshift mutagenesis. 
Specificity of Nth1 for a DHU lesion in different structural contexts 
We used direct competition experiments to measure the catalytic specificity of 
Nth1 toward DHU lesions present in different structural contexts. The specificity of Nth1 
is strongly dependent on ionic strength. This ionic strength dependence can be easily 
understood as a manifestation of a slow rate of dissociation from DNA substrates when 
the concentration of cations is low. At the extreme, kcat/KM is limited by the rate of DNA 
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association because every binding encounter results in successful reaction. This is 
expected to be a common situation, because many DNA binding proteins use electrostatic 
interactions to strengthen DNA binding We report the specificity of Nth1 at 200 mM 
concentration of cations, as a reasonable approximation of the salt concentration found in 
the cell. Experiments at higher concentration of sodium suggest that this condition 
underestimates the true catalytic specificity that Nth1 is capable of. Nevertheless, these 
data provide new insight into the recognition of DNA damage by Nth1. 
We found Nth1 has the highest catalytic efficiency for DHU•T, DHU•C, and 
DHU•G, with 10-fold reduced catalytic recognition of a DHU•A mismatch. Previous 
studies failed to detect a preference for DHU•G over DHU•A (27). However, these 
experiments were conducted at a low ionic strength concentration that would allow a 
significant contribution of non-specific DNA interactions to the overall analysis. Our 
measurements detected a mere 3-fold preference for DHU-G over DHU-A at an ionic 
strength of 100mM, whereas, a 100-fold preference was measured at 300mM ionic 
strength (Figure 4-3).  
It is expected that DHU•G is the structural context that occurs most often in vivo 
due to oxidation and deamination of cytosine. In contrast, replication of a DHU lesion is 
expected to incorporate an opposing A (42). Excision of DHU from a DHU•A pair would 
lead to C to T transition mutation. Discrimination by Nth1 against A leaves open the 
possibility for post-replicative repair that could target the A. There is precedent for such a 
pathway in the repair of 8-oxoguanine (8-oxoG). 8oxoG is initially formed paired to 
cytosine, but replication of 8oxoG supports incorporation of either cytosine or adenine 
opposing the 8oxoG lesion (41). 8-oxoguanine DNA glycosylase I (Ogg1) is specific for 
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8oxoG-C, excising the 8oxoG lesion (42). MutY is specific for 8oxoG-A, excising the 
adenine and retaining the 8oxoG lesion in order to allow another replication event to 
incorporate 8oxoG and lead to restoration of the correct G-C basepair (43). It is not 
known to what extent MutY is able to recognize a DHU•A pair.   
There are currently no structures available for human Nth1, but structural analysis 
of the Bacillus stearothermophilus homolog of Nth1 trapped with a reduced Schiff base 
illustrated that several contacts are established with a guanosine nucleotide that are absent 
with adenosine (30). There appear to be minor rearrangements in the protein backbone 
between the structures with a bound A and G that act to condense the protein structure 
around the guanine. However, it is not clear from these structures how pyrimidines could 
be accommodated by Nth1.  
Nth1 discriminates against excision of a DHU-bulge  
A primary objective of this study was to determine if Nth1 is able to excise a 
bulged lesion. Measured at 200mM ionic strength, Nth1 shows a 20-fold preference for a 
canonical DHU•G mismatch over a DHU bulge. The bulge is known to distort the DNA 
backbone. As Nth1 makes extensive contacts with the DNA backbone, is not surprising 
that Nth1 has a more difficult time engaging a bulge.  
Importantly, the maximal single turnover rate for DHU excision was the same for 
all structural contexts. Single stranded DHU lesion was an exception, incurring 
substantial reduction in maximal turnover rate. The maximal single turnover rate is 
measured under saturating concentration of enzyme and reports on all catalytic steps after 
substrate binding through the first irreversible step. Therefore, we can conclude that the 
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diminished specificity for DHU-A and DHU-bulge contexts are due to a reduction in 
affinity.  
In contrast, AAG showed a 3-fold higher affinity for a bulged lesion than a 
mismatched lesion. The catalytic efficiency for AAG excision of a mismatched lesion 
inversely correlated with the stability of duplex, specifically the interaction of the lesion 
with the corresponding opposing base (20). AAG makes no observable contacts with the 
opposing base, therefore, the absence of opposing base interactions is predicted to reduce 
the energetic barrier to base flipping. As both AAG and Nth1 make extensive contacts 
along the DNA backbone when engaging a lesion, backbone distortions caused by a 
bulged lesion may impair binding affinity. AAG may overcome the reduction in affinity 
by possessing an inherent flexibility in the DNA-protein interface, where Nth1 may lack 
the same extent of flexibility. 
Human BER processes a DHU bulge to a single nucleotide deletion 
Nth1 excision of a DHU-bulge initiates the BER pathway, ultimately leading the 
deletion of the bulged lesion. We reconstituted the short-patch BER pathway in vitro with 
recombinant human proteins to demonstrate that a DHU-bulge is efficiently deleted and 
each enzyme in the BER pathway functions as expected. We show that Nth1 can act as a 
monofunctional glycosylase, processing a DHU-bulge to a bulged abasic site. This 
activity utilizes the AP-endonuclease activity of APE1 and also requires the 5’-dRP lyase 
activity of polymerase β. Alternatively, long-patch BER could be realized by loading of a 
replicative polymerase at the nick site. Replicative polymerases have been shown to 
incorporate several nucleotides, displacing several nucleotides into a flap that is removed 
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by Flap Endonuclease I (FEN1). Importantly, both long patch and short patch pathways 
result in deletion of a bulged nucleotide. 
Bifunctional glycosylase/lyase activity was also observed for Nth1 catalysis of a 
DHU-bulge. Bifunctional activity nicks the bulged abasic site by a 3’-β-elimination to 
generate a 3’ block. APE1 can act as a 3’-phosphodiesterase to generate the 3’OH that is 
required for DNA ligation. This pathway occurs independently of polymerase β, the lyase 
activity conferred by Nth1. Under the experimental conditions employed, both 
polymerase β-dependent and independent reactions occur. The balance between these 
pathways depends on the relative levels of APE1 and Nth1 activity. 
DHU-bulge is efficiently converted to a single nucleotide deletion in HeLa nuclear 
extract 
 
We observed robust processing of a DHU lesion in HeLa nuclear extract. 
Depletion of divalent metals prevents nuclease processing. We exploited this property to 
measure the rate of glycosylase excision and found that a DHU-bulge is processed at 
twice the steady state rate as a DHU-G mismatch.  
Previous studies with Nth1 excision of a thymine glycol (Tg) lesion observed that 
the lower affinity Tg:A substrate displayed a higher steady state turnover rate than Tg:G. 
The authors proposed that the lower affinity substrate allows for a higher rate of product 
dissociation (44).  
Implications of glycosylase-initiated deletion of bulged nucleotides 
The ability of Nth1 to excise a bulged lesion is consistent with reports for other 
glycosylases (19, 20, 24). Therefore, efficient recognition of a bulged nucleotide appears 
to be a common for feature of glycosylases. It is possible that the flexible recognition of 
bulged nucleotides is a consequence of the need to bind to DNA in multiple 
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conformations to accommodate nucleotide flipping, in which case other base flipping 
enzymes might also have activity toward bulged DNA.  
Glycosylase interaction with a bulged nucleotide is expected to interfere with 
high-fidelity MMR activity. As detailed in this study, glycosylase excision of a bulged 
nucleotide can initiate the permanent deletion of the bulged nucleotide by BER. BER 
deletion pathway would prevent +1 frameshift mutations but make permanent -1 
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Figure C-1. DNA substrates used in this study. The centrally located nucleotide (X) is either 
a 5,6-dihydrouracil lesion or an undamaged cytosine. DNA labeled with a 5’-fluorescein 
attached by a 6-aminohexyl linker (6-fam). Duplex DNA is produced by annealing to an 
unlabeled, complementary strand. The nucleotide at position (Y) is one of four canonical 
nucleotides or omitted to form a bulged nucleotide at position (X). A six nucleotide polyT 
extension was affixed (25mer(T6)) to allow simultaneous quantification with 25mer in steady 
state kinetic assay. Terminal phosphorothioate and propane modifications were incorporated 
for exonuclease resistance in HeLa cell extract, as well as increased length for thermal stability 
at 37°C (35mer). A single phosphorothioate linkage is incorporated internally for 
endonuclease resistance. 
	  














































Figure C-2. Active concentration of recombinant Nth1 stock was determined by pre-steady 
state kinetic measurement under standard glycosylase assay conditions, 150mM [Na+]. (A) A 
rapid burst of abasic site produce is formed during the first turnover of 200nM DHU·G, 
corresponding to the concentration of active Nth1 molecules. A slow, steady state rate of DHU 
excision follows the burst phase. (B) The y-intercept defines the burst amplitude and increases 
linearly with Nth1 concentration, at a slope of 0.33. Nth1 concentration was estimated to be 100μM 






Figure C-3. Loss of Nth1 glycosylase activity at 4°C was quantified by measuring the initial 
rate of DHU-bulge excision. Separate aliquots of recombinant Nth1 (33μM) were thawed from 
-80°C stocks and stored at 4°C for the indicated time period. 20μl reactions containing 100nM 
DHU-bulge at 200mM [Na+] were incubated with 2nM Nth1 and 3μl aliquots were quenched in 
6μl 0.3mM NaOH and processed as previously described. A 7.5% decrease in activity occurred 
per day at 4°C, leading to a 38% decrease in glycosylase activity after 5 days. To alleviate the 
affects of Nth1 stability, aliquots of 33μM Nth1 were flash frozen and stored at -80°C. Aliquots 
were thawed and used immediately for assays. 
	  
A B 

























































Figure C-4. Non-enzymatic degradation of a DHU nucleotide leads to the formation of an 
abasic site. (A) Ring-opening of 5,6-dihydrouracil forms a 3-uridopropanoate moiety that is 
susceptible to N-glycosidic bond cleavage resulting in an abasic site product. (B) The rate of 
abasic site formation from a DHU containing oligonucleotide (25mer) was quantified at 95°C 
in annealing buffer. Annealing buffer contains 10mM NaMES (pH 6.0) and 40mM NaCl. 1μM 
5’-(fam)-labeled DHU containing strand was added with 1.5μM unlabeled complement strand 
and incubated at 95°C. Timepoints were taken by quenching 3μl aliquots in 6μl 0.3mM NaOH. 
Heating at 70°C for 10 min in alkaline conditions results in quantitative cleavage of abasic 
sites resulting from loss of DHU. In comparison, the stability of an oligonucleotide without a 
DHU lesion (A-T) was stable over entire timecourse. Rate of DHU degradation to abasic site 
was determined by fitting to a single exponential decay of substrate, eq C1, where S is fraction 
substrate at time, t. So is initial fraction of substrate and k is the rate of substrate decay. The 
rate of DHU degradation was 0.84% min-1 95°C.  
 
























































Figure C-5. Abasic site formation due to DHU degradation was quantitated by reduction of 
abasic sites with NaBH4. A reduced abasic site is protected from NaOH cleavage. Standard 
protocol for annealing oligonucleotides (25mer) requires melting DNA strands at 95°C for 5 min 
followed by slow cooling on ice over 30 min. (A) 20μL reactions contained 1μM 5’(6-fam)-labeled 
forward strand containing a centrally located DHU lesion was incubated with 1.5μM unlabeled 
complementary oligonucleotide in annealing buffer (pH 6.0). Reactions were subjected to standard 
annealing protocol and then reduced by addition of 1μL 500mM NaBH4 (in 10mM NaOH solution) 
on ice for 30 min. NaBH4 reduction was quenched by adding 1μL 85.2mM acetic acid and allowed 
to sit for 30 min on ice. Finally, 8μL solution of formamide loading buffer (with 40mM NaOH) 
was added and samples analyzed by denaturing PAGE. Lane 2 demonstrates the stability of a 
reduced abasic site to cleavage under alkaline conditions. Lane 5 shows significant formation of 
abasic sites occur during the standard annealing protocol, which are protected by NaBH4 reduction 
in lane 6. (B) Quantification of three independent reactions illustrates that over 20% of DHU 




























































Figure C-6. Annealing of 25mer oligonucleotides is performed by melting DNA at elevated 
temperature for 5 min, followed by slow cooling over 30 min on ice to promote correct 
hybridization of duplex DNA structure. (A) DHU is unstable at high temperatures, so the lowest 
melting temperature was selected that facilitates annealing. (A) 1μM 5’-(6-fam)-labeled 
oligonucleotide was incubated with 1.5μL unlabeled complement strand in annealing buffer (pH 
6.0) and subjected to the standard annealing protocol at various melting temperatures. A non-
denaturing native PAGE gel (20% acrylimide) demonstrated that 37°C allowed sufficient annealing 
of oligonucleotides while lessening degradation of DHU. Single-strand markers did not include 





















































Figure C-7. Determination of DHU stability in reaction conditions and alkaline workup. (A) 
1μM of the 25mer oligonucleotide containing a centrally located DHU·G mismatch or undamaged 
A·T basepair was incubated under conditions utilized for assaying Nth1 activity. After 24 hours, 
reactions in standard reaction buffer (23°C) were quenched into a final concentration of 0.2M 
NaOH and heated at 70°C for 10 min to cleave any abasic sites formed during the reaction. 
Reactions already in 0.2M NaOH were processed the same. Production of nicked DNA is 
indicative of abasic site formation and was quantified by denaturing PAGE analysis. These results 
demonstrate that a DHU lesion is stable in reaction conditions. (B) Typically, quantification of 
glycosylase activity requires cleavage of abasic sites in 0.2M NaOH at 70°C. At 70°C in 0.2M 
NaOH, abasic sites are formed by from a DHU lesion at a rate of 0.06% min-1. A burst of 2.85% is 
indicative of abasic sites already present in the DHU·G stock and results in a formation of 4.5% 
non-enzymatically produced nicked intermediate after 30 min. 10 min at 70°C was chosen as 
standard protocol for alkaline cleavage of abasic sites. Inset graph shows the percentage of non-




















Figure C-8. Relative kcat/Km values for a DHU lesion in different structural conformations were 
determined by competition. (A) A 6-nucleotide, polyT tract was attached to the 5’end of the 25mer 
oligonucleotide (see Fig. 1 for sequences) to allow simultaneous quantitation of two different substrates 
during steady state turnover. Abasic sites produced by glycosylase activity, as well as nicked 
intermediates produced by bifunctional AP-lyase activity, are cleaved to a 3’OH nick in alkaline 
conditions. (B) A typical denaturing polyacrylimide gel showing the timecourse of timecourse of a 
reaction with DHU·G (25mer) and DHU·T(T6) (31mer). Each oligonucleotide was present at 100nM 
and excision of DHU was catalyzed by 2nM Nth1.  
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Figure C-9. Bifunctional glycosylase/lyase activity produces a nick with a 3’-unsaturated 
sugar (3’-dR). Standard buffer conditions include 1mM dithiothreitol (DTT), which reacts with the 
α,β-unsaturated aldehyde to produce a lower mobility species (3’-dRX) in a bimolecular 
dependence (lanes 4 and 5). Incubating Nth1 with a DHU-bulge substrate produced a 3’ -dR nicked 
intermediate that was extracted using phenol-chloroform and a buffer exchange column. 1μM 3’-
dR intermediate was incubated in standard reaction conditions at 23°C. The reaction was quenched 
in formamide/EDTA loading buffer at 60 min. Substituting tris,2-carboxyethylphosphine (TCEP) 
for DTT prevents modification of the 3’dR intermediate (lanes 6 and 7). (B) Quantification of DTT 
reactivity with 3’-dR moiety at 23°C. Best fit of data to a single exponential with a rate of 
0.064min-1 and 0.11min-1 for 1mM and 5mM DTT, respectively. (C) Addition of 50nM APE1 (with 
5mM MgCl2) demonstrates 3’-exonucleolytic activity. APE1 removed the unsaturated sugar moiety 
and produced a 3’-OH intermediate within 60 min at 23°C (lane 4). Phosphodiesterase activity is 
























































Figure C-10. Incubation of oligonucleotides containing a DHU lesion showed BER 
activity in HeLa whole cell extract (WCE). Complementary to figure 4-9 from the main text, 
showing BER processing in HeLa nuclear extract (NE), 10nM oligonucleotide was incubated 
with 0.4 mg/ml HeLa WCE (Active Motif) at 37°C along with all cofactors necessary for BER 
activity. Reactions were quenched with formamide/EDTA loading buffer. Resolution by 
denaturing PAGE displays both formation of nicked BER intermediates (17mer) as well as 
production of single nucleotide deletion from a DHU-bulge.  
	  
	  














Figure C-11. Addition of 100nM competitor oligonucleotide in addition to 10nM DHU-bulge 
(35mer) substrate in HeLa NE facilitates more rapid and more complete BER processing of a 
DHU-bulge (35mer) to a deletion product (34mer). Competitor oligonucleotide is an unlabeled, 
unmodified 25mer and may serve to occupy some amount of non-specific DNA binding proteins in 
HeLa NE and allow BER to process the DHU lesion. (B) Quantitation of deletion product (34mer) with 
and without addition of competitor DNA. Points represent average of duplicate experiments (± standard 
deviation). Initial rate of deletion formation is increased 3-fold in conjunction with competitor 
oligonucleotide as shown by a linear initial rate (filled circles). In addition, the end-point of deletion 








CONCLUSIONS AND FUTURE DIRECTIONS 
 
The burden of damaged DNA poses a risk to genomic stability. A diverse array of 
DNA repair pathways have evolved to both repair damaged DNA, as well as correct 
replication errors. Insufficient DNA repair activity has been linked to an increased 
accumulation of mutations, leading to an increased risk of cancer (1, 2). For example, the 
hereditary or somatic downregulation of mismatch DNA repair (MMR) activity is well-
established link to genomic instability (3). Specifically, regions of repetitive sequences, 
termed microsatellites, become unstable in length due to increased frequency of insertion 
and deletion mutations. Microsatellite instability (MSI) is a hallmark of MMR deficiency 
and is used to clinically identify MMR deficient colon cancer (4, 5).  
It is known that polymerase slipping errors occur at elevated rates in 
microsatellite repeats, producing a bulged nucleotide that is an intermediate to a 
frameshift mutation (6, 7). A polymerase slipping error can insert an extra (+1 slip) or 
omit (-1 slip) a nucleotide in reference to the template strand during replication. 
Importantly, replication coupled MMR has the ability to differentiate the newly 
synthesized strand and provide accurate repair of either +1 or -1 slips. Downregulation of 
MMR fails to provide adequate repair of bulged intermediates and results in a higher 
frequency of frameshift mutations (8, 9). 
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  Paradoxically, upregulation of a DNA repair glycosylase, AAG, was correlated to 
MSI in patients with chronic inflammation of the colon (ulcerative colitis) (10). This 
observation was supported with studies to quantify the impact of AAG overexpression on 
frameshift mutation frequency. Overexpression of AAG produced a 6-fold increase in 
frequency of insertion (+1 frameshift) mutations and a 30-fold increase in deletion (-1 
frameshift) mutations. The proposed model accused hyperactive AAG activity for 
producing an excess of BER intermediates that overwhelmed downstream BER 
processing, and BER intermediates are known to be mutagenic (11, 12) (Figure 5-1A). 
Co-overexpression of the downstream BER enzyme, APN1 endonuclease, was predicted 
to alleviate the increased mutation rate by removing excess BER intermediates caused by 
AAG. Surprisingly, APN1 did not decrease the frameshift rate (10). These results are in 
contrast with a previous report documenting that the burden of BER intermediates caused 
by overexpression the yeast functional homolog of AAG, 3-methyladenine DNA 
glycosylase (MAG1), was alleviated by co-overexpression of APN1 (13). The inability of 
APN1 to rescue the increased frameshift mutation rate in the presence of AAG 
overexpression suggests that MAG1 and AAG induce frameshift mutations by differing 
mechanisms. 
Chapter 2 of this thesis provides an alternative model for AAG induced frameshift 
mutations. Following the initial observation that several different bulged lesions were 
excised in HeLa cell extract, reconstitution of the BER pathway in vitro demonstrated the 
ability of BER to convert a bulged lesion into single nucleotide deletion. The distinct 







Figure 5-1. Models to account for AAG overexpression induced frameshift mutations. (A) 
Hyperactive AAG produces excess of abasic sites (AP) in genome that overwhelms downstream BER 
processing. Unprocessed abasic sites induce frameshift mutations. (B) AAG excises damaged (X) or 
undamaged bulge to create a bias for -1 frameshift mutations by repairing +1 slip and thereby 
preventing +1 frameshift mutations. Template strand is indicated in black, newly synthesized strand is 
red. (C) AAG binds to bulges and prevents repair by MMR. A subsequent round of replication 





nucleotide. Once the bulged nucleotide is excised, the DNA backbone can be cleaved at 
the resulting abasic site. The absence of a template base opposing the bulged nucleotide 
allows the site to be ligated without addition of a new nucleotide, resulting in the deletion 
of the bulged nucleotide (14). 
There are 11 known human glycosylases, each providing recognition of a single 
or a subset of damaged nucleotides. Therefore, the impact of the BER deletion pathway 
on the frequency of frameshift mutations would likely be influenced by both the number 
of glycosylases capable of excising a bulged nucleotide, as well as the identity of the 
bulged nucleotide. Characterization of AAG in chapter 3 showed the excision of an 
inosine lesion is 3-fold more efficient in a bulge than in a mismatch. Therefore, AAG has 
no inherent ability to discriminate against excising a bulged nucleotide. In contrast, a 
similar characterization of a different human glycosylase, Nth1, in chapter 4 showed a 
20-fold discrimination against excision of a bulged lesion. These two examples, in 
combination with additional reports, provide evidence that excision of a bulged 
nucleotide may be a common feature of glycosylase catalysis (15, 16). All glycosylases 
require the target nucleotide to be flipping out of the duplex DNA and into the active site 
prior to catalyzing nucleotide excision, and a bulged nucleotide may lower the energetic 
barrier to baseflipping. Nevertheless, distortions in the DNA structure induced by a 
bulged nucleotide structure does affect glycosylase catalysis to various extents, although 
it is unclear what steps in glycosylase catalysis are being affected by the bulged 
nucleotide.  
Ultimately, BER deletion of a single nucleotide bulge would produce a bias for -1 
frameshift mutations by repairing +1 slipping errors (insertion) and making -1 slipping 
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errors (deletion) permanent (Figure 5-1B). Therefore, the BER deletion model can 
account for the bias for -1 frameshifts observed with AAG overexpression, but does not 
explain increased formation of +1 mutations. A model that does account for formation of 
both +1 (insertion) and -1 (deletion) frameshift mutations was proposed (17). This model 
incorporates AAG binding with high affinity to a bulged intermediate, blocking repair 
activity by MMR. A subsequent round of replication would convert the unrepaired 
bulged intermediate into a frameshift mutation. Consequentially, AAG would block 
repair of both +1 and -1 slipping errors and lead to the formation of both +1 and -1 
frameshift mutations (Figure 5-1C). 
These two models do not need to be mutually exclusive. A combination of both 
models would elegantly explain the observed affect of AAG overexpression on 
frameshift mutation rates. The binding of AAG to bulged intermediates without excision 
would explain the elevated rate both +1 and -1 frameshift mutations due to disruption of 
MMR activity. The observed bias for -1 frameshift mutations can be accounted for by 
AAG excising the bulged intermediate and allowing BER to delete the bulged 
intermediate. The contribution of either pathway to BER mediated frameshift mutations 
can be addressed with further experiments.  
Classically, a genetic reversion assay in S. cerevisiae based on auxotrophic 
selectable marker has been utilized for measuring the frequency of frameshift mutations 
(18-20). This well-established tool for measuring the frameshift mutations rate utilizes an 
engineered homopolymeric run into the lys2 gene. Lys2 is an α-aminoadipate reductase, 
playing an essential role in biosynthesis of lysine (21). Functional Lys2 can be selected 
against by addition of α-aminoadipic acid. α-aminoadipic acid is metabolized by Lys2 
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reductase activity to build toxic levels of the δ-semialdehyde intermediate. Alternatively, 
Lys2 function is auxotrophic selectable by growth on minimal media lacking lysine (20). 
The affect of AAG overexpression has been documented using the Lys2 genetic 
reversion assay (10). This study reported a 6-fold increase in +1 and a 30-fold increase in 
-1 frameshift mutations in the presence of AAG overexpression. In order to measure 
reversion of both +1 and -1 frameshift mutations, two strains are constructed. Both strains 
are designed to have lys2 shifted one nucleotide out of frame, reverting to functional 
Lys2 after incurring a frameshift mutation (20).  
Expanding on these results, conditions can be perturbed to enhance the bias for 
different models of AAG induced frameshift mutations. Inactivating the glycosylase 
activity of AAG by mutation of an essential glutamate (E125A) disallows processing 
through the BER deletion pathway. Inactive AAG overexpression resulted in a significant 
decrease in the frequency of frameshift mutations and reduction in the bias for -1 
frameshift mutations (17).  
Alternatively, elevated levels of DNA damaging chemicals would be expected to 
enhance the bias for -1 frameshift mutations by enabling higher flux through the BER 
deletion pathway. As stated above, the bulged nucleotide can be more susceptible to 
chemical reactions with DNA damaging agents and damaged nucleotides are excised at a 
much higher rate than undamaged, bulged nucleotides (14). Chloroacetaldehyde has 
proven specificity for damaging bulged nucleotides and can be added to yeast growth 
media to increase the probability of producing a bulged lesion. However, the cellular 
chloroacetaldehyde concentration must be optimized to increase the probability of 
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creating a bulged lesion while minimizing adverse damage to the genome and other 
cellular biomolecules. 
Alternatively, a single mutation in AAG has been shown to significantly increase 
the rate of undamaged guanine excision (22). This mutant (N169S) could be employed to 
enhance the glycosylase excision pathway in the absence of DNA damaging agents due 
to excision of undamaged, bulged guanine. Characterization of the N169S mutant showed 
an inverse correlation with basepairing stability and efficiency of guanine excision, a 
property that would be expected to aid in selection for bulged guanine excision. 
Nevertheless, the expression of N169S mutant protein must be carefully controlled to 
avoid excess excision of basepaired guanine throughout the genome. 
An important limitation of measuring frameshift frequency by genetic reversion is 
that only a single site is tested in a single experiment. Next generation sequencing 
techniques are an attractive approach to quantify the frameshift mutations over the entire 
genome. This approach sequences an extremely large number of short lengths of the 
genome (100 nucleotides) in parallel. The sequences are then mapped to a reference 
genome. Recently, the technological advances in both the technique and analysis of next 
generation sequencing will facilitate accurate determination of indel mutations in 
homopolymeric and other repetitive sequences.  
An advantage of whole genome sequencing is the ability to correlate the 
contribution of genomic features to frameshift mutation frequency. Specifically, 
nucleosome positioning, epigenetic markings, and gene transcription rates have been 
characterized across the genome and could utilized to correlate frameshift mutation 
frequency with features of the genome (23). For example, DNA repair activities are 
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restricted on nucleosomal DNA (24, 25). Similarly, nucleosome positioning has been 
shown to influence the exposure of the DNA to damaging agents (26, 27). Taken 
together, the overall mutation rate at a specific genomic position may be governed by the 
level of exposure to DNA damaging agents as well as the ability of DNA repair to 
function efficiently. 
Correlation of mutation rates with features of the genome requires consideration 
of the dynamics of the genome, as many features of the genome are not static. Some 
changes are transient, for example, a replication event removes histone structures from 
the DNA (27). Additionally, cell cycle dependent fluctuations of DNA repair activity and 
exposure of DNA to damaging agents may provide significant, yet transient alterations in 
mutation rates. The most intriguing influences to frameshift mutation rate, uncovered by 
whole genome sequencing, can be studied in greater detail by employing the established 
in vitro assays for detecting single nucleotide deletions (14). 
In conclusion, these models supply explanation of how the overexpression of 
DNA glycosylases can lead to increased mutation rates, highlighting that the 
glycosylase’s unique ability to recognize a structurally diverse range of substrates must 
be carefully balanced to avoid superfluous activity leading to mutations. Downregulation 
of DNA repair activity is well-established to increase the mutation rate due to mutagenic 
intermediates remaining in the genome in the absence of repair. Surprisingly, the 
upregulation of BER repair pathway can lead to an imbalance in repair activities and 
conditions that reduce the probability of correct repair of frameshift mutation 
intermediates. Therefore, maintaining the highest level of genome stability requires 
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carefully balanced levels of DNA repair pathway activity, ensuring that the appropriate 
pathway is utilized to provide the greatest fidelity of repair.  
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